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editorial

One World (Not Three)
I was a mere babe-in-arms when my parents dragged my
brothers and me across an ocean and most of a continent to
settle in Canada. Once, being an immigrant meant staring
open-mouthed at the ESL teacher and mailing birthday
cards that took three months to arrive. Now, it means
heated, multilingual video-debating with relatives half a
world away as all involved watch the same live newscast
about events in a third place altogether.
With continual improvements in the affordability
and convenience of international travel, trade, and
information exchange, stories like mine are becoming
more commonplace and monikers like “global village” are
becoming increasingly apt for describing the world. Modern
telecommunications and transport are progressively
overcoming the challenges posed by physical separation,
bringing the rest of the world quite literally closer to home.

Other contributors discuss the proper way to manage
Canadian healthcare, given its global context.
Overwhelmingly, the message is that one size does not
fit all: refugees and other newcomers are deserving
and in need of aid, and complementary and alternative
medicines popularized by cultural practices merit
individual consideration.
The stories told in this issue hail from all over the world,
many in places far from here, but as Sting would have us
know, that all “gets a little closer every day.” The health
and well-being of those living on the other side of the
world do and should matter to us. So, for less than the
price of a bus fare to the airport, let the UWOMJ take you
on a highlights tour of the global healthcare landscape.

Anthony Chow
Senior Associate Editor

Still, geography continues to matter and stories vastly
unlike mine remain the norm. The International
Telecommunications Union estimates, for example, that 77%
of the developed world is connected to the Internet while only
31% of the developing world can say the same. Accordingly,
the WHO finds that low income countries contend with
twice the number of disability-adjusted life-years per capita
than high income countries do. Clearly, people and ideas
might be moving faster, but they’re not reaching many parts
of the world that are in need. In this issue of the UWOMJ,
we explore some of the causes and consequences of these
disparities, both in Canada and abroad.
Some of our contributors, inspired by personal interest and
experiences abroad, choose to explore the challenges of
medical provision in locales and through systems different
from our own. These run the gamut from the everyday
headaches of providing safe and cost-effective nutrition,
surgery, and diagnostics to the difficulties of managing oncein-a-lifetime infectious disease or natural disaster crises.
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A clinical tool for evaluating complementary
and alternative medicine utilization and risk
Keegan Guidolin (Meds 2017), Mackenzie Drew (BSc Cand)
Faculty Reviewer: Dr Michael Craig, MD, CCFP (Department of Family Medicine)

abstract
Complementary and alternative medicine (CAM) is widely
used in Canada and throughout the world, making it inevitable that family physicians will encounter CAM use in their patients. CAM therapies are highly variable and are not subject
to regulation or oversight, making some such modalities potentially dangerous. Presently, CAM use is discussed during standard history taking, but the information gathered may be of
limited utility due to the wide variety of CAM that exists; such
diversity makes it practically impossible for one physician to
know the risks associated with each CAM. Additionally, some
CAM may not identified as such by the patient (eg chiropractic) and may not be reported during a standard patient interview. There currently exists no standardized method of collecting a patient’s history of CAM use, or for assessing risk based
on the information collected. Here, we present a clinical tool
that helps to screen for use of CAM and stratify patients into
risk categories accordingly. It also makes suggestions for management and follow-up of these patients according to their risk
category. Included are several quick reference tables to enable
physicians to rapidly stratify patients into an appropriate category. This test may help to screen patients for CAM use that
puts their health at risk, thereby increasing detection, and enabling timely intervention by the physician to prevent adverse
events due to CAM use.

background
Complementary and alternative medicine (CAM) is defined by
the Canadian Medical Association and United States National Institutes of Health as “a group of diverse medical and health care
systems, practices, and products that are not presently considered
to be part of conventional medicine.” For this reason, they are not
subject to the same standards of scientific scrutiny that conventional therapies are, and consequently, many are of questionable legitimacy and safety.1 Regardless, several surveys done over the past
20 years have consistently indicated that 70% to 75% of Canadians
have used CAM at least once in their lifetime.2-4 Despite the high
prevalence of CAM use in the Canadian population and its ability
to affect the health and safety of a patient, it can go unaddressed or
undisclosed in the family physician’s clinic.5
CAM can be most usefully divided into three categories: products, interventions, and practitioners. Products include items typically bought by consumers, such as herbal teas and remedies, vitamins and minerals, homeopathic remedies, traditional Chinese
medicines (TCM), and many others. Interventions refer to practices such as spinal manipulation, electromagnetic field therapy, crys-

tal healing, and others which may or may not involve a practitioner.
Practitioners are individuals who market themselves as care providers in particular fields, such as chiropractic, TCM, homeopathy,
naturopathy, Ayurveda, acupuncture, and others. Practitioners may
or may not prescribe or provide both products and interventions.1

cause for concern
While some regulatory bodies exist for mainstream therapies,
CAM is poorly regulated overall.6-8 Due to poor regulation and the
lack of medical education of most practitioners, CAM can pose
significant threats to the health of Canadians through a variety of
mechanisms:
• The traditional Chinese herb ma huang contains unregulated
levels of ephedrine and can cause numerous adverse effects
including palpitations, hypertension, arrhythmia, nervousness,
tremors, seizures, heart attack, stroke, and death.9
• Ginseng is a naturopathic remedy marketed under the name
COLD-FX as an immune system booster that will prevent viral
influenza and strengthen normal body function, among other
such claims. Serious drug interactions with warfarin have been
described, as well as stimulation of manic episodes in psychiatric patients on antidepressants.10
• Ayurvedic medicine is a form of traditional Indian medicine
that stresses the use of plant-based therapies, yet Ayurvedic
medicines have been shown to contain toxic levels of heavy
metals; one study found that one in five Ayurvedic herbal medicine products contained potentially harmful levels of lead,
mercury, or arsenic.11
• Chiropractic is an intervention which focuses on spinal manipulation therapy, often marketed as a panacea, but numerous
serious adverse effects have been reported as a result of chiropractic manipulation, including stroke, neuropraxic injury,
epidural hematoma, paraplegia, and fatal posterior circulation
cerebrovascular accident.12-15
• Acupuncture is a component of some TCM and involves puncturing a patient’s skin with needles along so-called meridian
lines to achieve therapeutic effect. Numerous systematic reviews, multi-centre trials, and prospective studies have highlighted the dangers of acupuncture, finding that it can cause
pneumothorax, hepatitis C, septicemia, endocarditis, local skin
infection, perichondritis, arthritis, osteomyelitis, and many less
serious side effects such as hematoma, slight hemorrhage, and
dizziness.16-20
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This represents a brief illustration of the dangers posed by CAM
therapies. Of course, all medical therapies carry some risk; however,
in the cases of most CAM, no benefit has been shown via randomized
controlled trial, making the risk-benefit calculation one-sided.21
Not all CAM poses a direct threat to health. CAM is a catch-all
term which should be parsed for clarity: complementary medicine
is unconventional therapy used concurrently with conventional
therapy, while alternative therapy is unconventional therapy used
exclusively, in place of conventional therapy. This is an important
distinction because an individual using alternative medicine is, by
definition, foregoing conventional treatment — this poses an entirely different threat.22 CAM such as homeopathy, crystal healing, and
reiki poses no direct threat, but may prevent people from seeking
appropriate medical attention.

the cam risk assessment tool
Numerous studies involving CAM have highlighted the need
for a better method of assessing, following, and managing CAM-using patients.21 Here we present a clinical tool intended for use by

the family physician, or any physician following a patient for an
extended period of time. This tool represents a means of assessing
patients’ use of CAM and risk of associated harm, and classifies patients into categories with targeted indications for follow-up. This
tool is designed to be used when taking the initial patient history
for a new patient in a family practice, but may be implemented at
any time.
The tool itself consists of three components: (1) a set of initial
questions to determine whether or not the patient uses CAM (CAM
determination), (2) a set of questions to determine the qualitative potential for harm as a result of CAM use, and (3) a set of questions to
determine whether the patient uses CAM exclusively (alternatively)
or alongside conventional medicine (complementarily). These question sets help to quickly and easily stratify patients into risk categories (Figure). Each question set is aimed at evaluating the use of CAM
from each of the three categories (products, interventions, and practitioners). These questions are meant only to screen for CAM which
the patient may not consider outside of conventional medical care.
For example, patients may consider chiropractic manipulation con-

Figure: CAM risk assessment tool.
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Table 1: Summary and Indications: Class Definitions and Corresponding Management Considerations

class

management considerations

CAM 0 (No CAM)

• Repeat screen at periodic health assessment (PHA).

CAM IA
• Complementary
• Likely harmless

•
•
•
•
•

Education regarding lack of evidence for CAM.
Encourage physician consultation before starting new therapies.
Contact CAM practitioner, open communications regarding treatment prescribed.
Works towards dispelling CAM use, move patient towards CAM class 0.
Re-evaluate at PHA.

CAM IB
• Alternative
• Likely harmless

•
•
•
•
•
•

Non-aggressive discussion recommended — trust in mainstream medicine and physicians may be tenuous.
Gain patient trust.
Work towards a CAM class IA designation before addressing lack of evidence for CAM.
Contact CAM practitioner, open communications regarding treatment prescribed.
Address immediate health concerns at physician’s discretion.
Follow patient closely.

CAM IIA
• Complementary
• Potentially harmful

•
•
•
•
•
•

Education regarding lack of evidence for CAM.
Encourage physician consultation before starting new therapies.
Contact CAM practitioner, open communications regarding treatment prescribed.
Address harmful effects of CAM (eg heavy metal screen in Ayurveda use).
Advise against use of harmful CAM.
Pediatric: Refer to Children’s Aid Society (or analogue) at physician’s discretion.

CAM IIA
• Alternative
• Potentially harmful

•
•
•
•
•
•
•

Non-aggressive discussion recommended — trust in mainstream medicine and physicians may be tenuous.
Address immediate health concerns.
Gain patient trust.
Work towards CAM class IIA initially.
Contact CAM practitioner, open communications regarding treatment prescribed.
Advise against use of harmful CAM only if patient is open to the idea.
Pediatric: Refer to Children’s Aid Society (or analogue) at physician’s discretion.

ventional medical treatment when a physician asks. The questions
are not meant to be exhaustive and follow-up questions are necessary
for an adequate assessment of CAM use.
Included is a patient scoring system and score-dependent
management recommendations (Table 1). These should be taken
only as a list of options to consider based on the relative risk. They
are not meant to be exhaustive, nor are they meant to be applied to
every patient—naturally, the physician must apply the entirety of
this tool on a case-by-case basis. To help simplify the application of
the tool, two Quick Reference Charts are included. The first is a list
of types of CAM practitioners; patients who identify any of these
practitioners as someone they regularly see for health advice can
be considered to use CAM (Table 2). The second is a list of CAM
modalities stratified into likely harmless and potentially harmful
categories based on literature review (Table 3). The use of this table
helps to determine a patient’s risk of harm (CAM class I vs II).
The ultimate goal of the management considerations presented
by this tool is the reduction and eventual elimination of CAM use by
the patient. This is theoretically achieved over multiple visits, with
CAM score reassessment at each; however, particular care should
be taken in a few situations. Firstly, in cases of CAM class B, or use
of alternative medicine, care must be taken to avoid confrontation.
Since these patients use CAM as an alternative, their trust in mainstream medicine may be tenuous, and thus, if a physician addresses
CAM use too aggressively, patient trust may be lost and the patient
may be lost to follow-up. Secondly, special attention should be given
if a child is being treated with CAM, particularly CAM class II (po-

Table 2: Practitioner Quick Reference: List of CAM Practitionersa

a

Acupuncturist

Homeopathic doctor

Aromatherapist

Naturopath/Herbalist

Astrologer

Osteopathic doctor

Chiropractor

Reflexologist

Crystal Healer

Shaman

Holistic doctor

Traditional Chinese medical doctor

Self-identified as CAM practitioners in survey and promotional publications.22,23

Table 3: Harm Quick Reference: Likely Harm Associated with Complementary
Use of Common CAM
Likely harmlessa

•
•
•
•
•

Acupressure/shiatsu24
Faith healing/prayer25
Hypnosis26
Magnetic healing27
Reiki/therapeutic touch28

Potentially harmfulb

•
•
•
•
•
•
•

Acupuncture16-20
Ayurvedic medicine11
Chiropractic12-15
Colonics29
Herbal supplementationc,10,30
Homeopathic medicine31
Traditional Chinese medicine9,32

a

Harmlessness is not an endorsement of CAM effectiveness.
Harm classification based on complementation of conventional care; alternative care has
inherent risks.
c
Unregulated or poorly regulated.
b
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tentially harmful CAM). Continued use of potentially harmful CAM
on pediatric patients in the face of physician advice to the contrary
raises serious concerns regarding abuse, and the involvement of
the Children’s Aid Society and analogous groups may be indicated. Ultimately, follow-up is key in both of these scenarios, as the
patient-physician relationship should be developed and leveraged
appropriately to ensure the health of patients who use CAM.

limitations and future directions

12.
13.

14.

The relative lack of existing research on the consideration of
CAM as a risk factor for future medical conditions makes a tool like
the one presented here inherently qualitative in nature. It is difficult to make empirical risk evaluations or evaluate the effect of the
management considerations listed here in a quantitative fashion. As
such, this tool is presented as a means of standardizing the CAM
component of a patient history in order to act as a screen. Primarily, this tool aims to help physicians take a more complete history
with regard to CAM use in their patients. Future studies may assess
whether the use of this tool increases detection of CAM use in patients at the level of the primary caregiver.
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Surgical hygiene
Refining the WHO Safe Surgery Saves Lives guidelines
Alexander Levit (Meds 2017), Denise Darmawikarta (Meds 2016)
Faculty Reviewer: Dr Javeed Sukhera, MD (Department of Psychiatry, Office of Global Health)

abstract

the checklist

Overwhelming rates of postsurgical adverse outcomes have
been recognized to be preventable. As a means of minimizing the
incidence of iatrogenesis, in 2005 the World Health Organization
(WHO) launched the Clean Care is Safer Care campaign, which
focused on the importance of hand hygiene. Following its success,
the WHO hoped to utilize similar strategies in their Safe Surgery
Saves Lives campaign, which began in 2007. Despite active efforts
to implement the associated 19-step surgical checklist, resource
limitations restrict the full potential of such harm reduction strategies. Here, we discuss current evidence evaluating the effectiveness of the WHO’s surgical checklist and address challenges with
respect to its application in the real world.

The cornerstone of the Safe Surgery Saves Lives recommendations is a 19-step surgical safety checklist that includes items for review
prior to induction of anaesthesia and skin incision and before the patient leaves the operating room. An accompanying manual guides the
clinician through proper use of the checklist. Checklist items include
more universal perioperative considerations, such as patient identification, consent and proper site of surgery, and more specific instructions, such as a prompt for two intravenous access points if more than
500 mL of blood loss is anticipated. Communication of procedural or
patient-specific concerns is also encouraged between members of the
surgical team (nurse, anaesthetist and surgeon).
A large pilot study appraised the benefit of the WHO checklist
in 8 hospitals around the world. The rate of perioperative death from
noncardiac surgery averaged 1.5% (n = 3733) before intervention, and
decreased significantly to 0.8% (n = 3955) after checklist training and
implementation.3 In the same population samples, inpatient complication rates also decreased significantly from 11.0% to 7.0%. These
statistics align well with the estimate that half of surgical injuries are
preventable and suggest that the checklist can accomplish a meaningful reduction in these events. However, the study is plagued by
several limitations. The researchers of the study pointed out that surgical team performance may have improved during use of the checklist as it could have heightened the teams’ awareness that they were
being observed. They also noted that patient complications were only
observed up until discharge, suggesting that the incidence of postsurgical complications could have been underestimated.
It is important to note that the above study may lack generalizability. While 4 of 8 hospitals belonged to low- or middle-income
countries, only one hospital was not a large tertiary hospital in an
urban centre. This lack of diversity raises concerns regarding the applicability of the study results to a broader range of hospital settings,
specifically smaller or rural facilities. Pulse oximetry and prophylactic antibiotics were identified in the study as requiring the commitment of significant resources, and were available at the low-income sites but used inconsistently prior to checklist intervention.
The study made no comment on whether the increased use of these
resources placed any strain on hospital supplies. Given the estimate
that half of the world’s population lives in a rural setting,8 it was also
misrepresentative to recruit only one rural hospital. Though recruitment of hospitals from more truly diverse settings would have yielded more convincing data, herein could arise the problem of global
variability. For instance, pulse oximetry was considered to be a superfluous checklist item for United Kingdom (UK) anesthetists as it
is standard.5 Meanwhile, in developing countries, where preventable
mortality attributed to anaesthesia can be as high as 1 in 150,9 pulse

introduction
Iatrogenic injury, inadvertent harm or illness caused by medical therapy, remains a significant issue due to its impacts on patient
outcomes and physician practice. To address the persistently high
incidence of iatrogenesis, the World Health Organization (WHO)
passed a resolution in 2002 that identified patient safety as a global priority. This prompted a series of internationally coordinated
awareness campaigns. The first campaign began in 2005, was entitled Clean Care is Safer Care and emphasized proper hand hygiene and recommendations for improved sanitation practices. As
of 2013, 15 700 health care facilities worldwide have committed to
the WHO guidelines for improving hand hygiene.1
The second WHO campaign, Safe Surgery Saves Lives, began
in 2007 and aimed to reduce preventable causes of surgical complications. It is estimated that 234 million surgical operations are
performed annually around the world,2 with 3% to 17% of procedures resulting in major complications and 0.4% to 0.8% in perioperative death.3 At least half of these adverse outcomes are thought
to be preventable, quantified as approximately 468 000 preventable
deaths every year.3 While the statistics urge a widespread harm
reduction intervention, the complexities of surgical error make it
much more difficult to address than hand hygiene. Hand hygiene
guidelines that were put forward in the Clean Care is Safer Care
campaign were effective because they followed the principles of
simplicity and wide applicability. In contrast, the crucial and resource-sensitive challenges of surgery that are specific to any one
ward, hospital or country can be too unique for wider application.
Despite these challenges, the most recent WHO guidelines optimistically state that these same principles will be maintained in the
Safe Surgery Saves Lives campaign.4
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oximetry may frequently not be available and a serious shortage of
trained anaesthetists may be a more pressing issue altogether.10,11
Additionally, a smaller independent study on the implementation of the checklist suggested that certain surgical subspecialties
will need to modify the checklist. For instance, orthopaedic surgery
will benefit from checking for prophylaxis against deep vein thrombosis.5 The WHO guidelines advise additions and modifications of
the checklist to fit local practice, but do not address the inherent
problems created by a list that becomes too lengthy. Research suggests that when a list becomes too exhaustive, there is an increased
likelihood for any checklist item to be overlooked.6 Furthermore,
studies in aviation have pointed out that a poorly executed checklist
can give a detrimentally false sense of security.7
While these limitations may be amenable to optimization
through modifications of the checklist and its implementation, matters of resource limitation, as discussed previously, could pose even
greater challenges to the checklist’s effectiveness. One UK anaesthetist accurately captured this issue in a comment on the checklist: “It
is a bit artificial sometimes. It’s trying to be everything to every nation
and to every standard of medicine.”5

the best standards checklist
As it stands today, the current checklist and guidelines aim to
be widely applicable by falling somewhere in between ideal and
resource-limited surgical safety standards. This results in a dichotomous insufficiency. For affluent regions with developed medical
infrastructures, the checklist may be too basic and the benefit of the
checklist restricted. On the other hand, for poorly-funded facilities,
where the training or resources indicated on the checklist may not be
available, the checklist would be unusable. We suggest that it would
be more appropriate to maintain an updated checklist that focuses on the best standards of patient safety given the best reasonably
available surgical resources. This, in combination with knowledge
exchange and capacity-building strategies, may best pave the way to
safer surgeries. Such a position would not neglect the right to safe
surgery for patients in low- and middle-income countries; rather, it
would recognize the more pressing issues of surgical availability and
accessibility where they are limited.

where availability & accessibility are a graver concern
Though it may be beyond the scope of the WHO patient safety
program to supply surgical resources to developing countries, it is
imprudent of the Safe Surgery Saves Lives campaign to neglect this
more critical challenge to safe surgical care. Given the importance
of minimizing iatrogenesis, the developing world would be better
served by the distribution of information on the safety of adaptations
made for resource-limited surgery instead of financially inappropriate recommendations. Surgical innovations discovered in low- and
middle-income countries have been very cost-effective but due to
safety concerns and lack of knowledge dissemination, these innovations may take a long time before they are globally appreciated and
adopted.12 Many such innovations like the Bogotá bag, the use of a
mosquito net mesh for inguinal hernia repair, and manual small incision cataract surgery have drastically improved global surgical care.12
It would also serve the additional benefit of helping to dispel the il-

lusion that essential surgeries cannot be affordable or cost-effective
in developing countries.13 Indeed, the Safe Surgery Saves Lives campaign has already endorsed the Lifebox, a more affordable yet still
reliable pulse oximeter developed by a nonprofit organization.14

conclusion
While hand hygiene is relatively a more globally achievable measure, global surgical safety involves more procedure-specific guidelines and is more resource-sensitive. Simplicity and wide applicability
helped to make the Clean Care is Safer Care campaign a success, but
Safe Surgery Saves Lives could be made more successful with a more
appropriate and stratified approach. We propose the following:
1. Specific guidelines should be adapted for specific areas of
surgery.
2. Up-to-date checklists should be maintained and based on the
best standards of care, with fewer superfluous checklist items.
3. More parallel effort should be made to endorse and disseminate safety information on surgical innovations adapted for
resource-limited facilities.
This approach would help to improve both the safety and the accessibility of surgery on a global scale. Though preventable patient harm is
a global issue, improving the safety of surgery requires local measures.
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abstract
Despite advances in treatment and diagnosis, malaria continues to cause a significant number of deaths, particularly in
African children.1 Optimized diagnostic and follow-up testing
is required for appropriate treatment and eventual eradication of malarial disease in sub-Saharan Africa. Microscopy is
compared to rapid diagnostic testing (RDT) for use in a low-resource setting.

introduction
Malaria is a curable disease caused by the infection of red
blood cells with the parasite Plasmodium, a protozoan transmitted between carriers via bites from infected Anopheles mosquitos.
According to the World Health Organization (WHO), malaria is
responsible for between 473 000 and 789 000 deaths worldwide
per year.1 Most deaths occur in children living in Africa, though
elderly individuals, immunocompromised pregnant women and
previously unexposed travellers are also at increased risk of experiencing severe disease in endemic areas.1,2 Chronic infection
with the parasite results in partial immunity; individuals infected
for the first time are the most vulnerable to complications of the
disease, whereas those with chronic infections often become asymptomatic carriers.1 Malarial illness typically presents with fever, chills and vomiting, making its differential diagnosis difficult
, and may result in severe complications or death if left untreated.2
Common complications observed in children include anemia, metabolic acidosis and cerebral malaria, whereas adults with severe
disease are more likely to develop multi-organ failure.1 Childhood
infection with malarial parasites has also been associated with increased prevalence of chronic anemia and status epilepticus in Africa.3,4 Thus, access to accurate and reliable diagnostic technology
could help to reduce the burden of malaria-associated deaths and
complications.1-4 Further, lack of accessibility and incorrect use of
diagnostic technology has resulted in overprescription of antimalarial drugs.2 Widespread use of artemisinin monotherapy, rather
then the gold standard artemisinin combination therapy (ACT),
and discontinuation of antimalarial drugs based on symptom resolution rather then clearance of infection have contributed to the
development of artemisinin-resistant strains in some geographical
areas.5 The widespread dissemination of resistant strains could
be devastating as methods of identifying and treating drug-resistant malarial strains have not yet been developed.5 Improved accessibility to accurate malaria diagnosis in sub-Saharan Africa is
necessary for elimination of malaria as it ensures that individuals presenting with fever are treated appropriately, thus reducing
overprescription and transmission to more vulnerable populations.

Though several tests exist for the diagnosis of malaria, there
are many challenges to implementing them in sub-Saharan Africa.
Previous efforts to eliminate malaria in this setting have failed despite the availability of diagnostic testing. Possible barriers to implementation may include poor infrastructure maintenance, lack of
trained microscopy personnel, expiration or degradation of testing
materials caused by heat and humidity, high financial costs and
lack of quality control measures. In order to increase accessibility
to testing in this setting, tests need to be sensitive and specific, but
also easy to use, able to provide results rapidly and tolerant of poor
storage conditions. This article will discuss the benefits and drawbacks of two commonly used technologies: microscopy and rapid
diagnostic testing (RDT).

microscopy
Microscopy with Giemsa staining is considered the gold standard for diagnosis of malaria.6 Several different methods of microscopy are currently available. Thick blood smear microscopy examines
a larger volume of blood and is thus useful for determining whether
the parasite is present.6 Thin blood smear microscopy is less sensitive
because a smaller volume of blood is used, but is more effective at
determining parasite species: as such, it gives valuable information
about a patient’s risk for complications and the appropriate course
of action.6
Microscopy performed in a clinical setting with skilled personnel is the most sensitive form of testing available for malaria diagnosis; detection of parasitemia can occur at concentrations of 4 to 20
parasites per µL.6 However, this level of sensitivity is achievable only
by experienced microscopists with adequate supplies and training.7,8
Field studies in Africa have demonstrated that parasitemia levels as
high as 50 to 100 parasites per µL may be required for detection of
malaria in local laboratory settings.7,8 Several studies conducted in
febrile patients diagnosed with malaria have found poor agreement
between regular microscopy and research microscopy and suggest
that antimalarial overprescription rates may approach 50% in some
areas.9 Sensitivity and specificity of regular microscopy was also
found to vary considerably among different facilities, suggesting that
the efficacy of microscopy is dependent upon the expertise of the microscopist.9,10 Several studies have been conducted in an African setting comparing routine microscopy to research microscopy. Results
suggest that routine microscopy performs poorly in low-resource
settings, with one trial finding that positive tests were confirmed by
research microscopy only 43% of the time and the other, a study conducted in Dar es Salaam, finding only a 47% specificity for routine
microscopy.2,10 It is therefore not surprising that a survey conduct-
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ed of clinicians in Tanzania found that only 41% considered malaria
results from their local laboratory to be reliable.11 Reasons cited for
poor laboratory performance include lack of equipment or stain, lack
of training and low job motivation.11 Further, in both Ghana and Malawi, it was found that treatment is frequently administered despite
negative test results.12 Thus, though microscopy can be highly effective at detecting parasitemia and differentiating between species of
malaria, in the absence of appropriate resources and skilled technicians, it loses its diagnostic efficacy and may contribute to the overprescription of antimalarial drugs.

rapid diagnostic testing
Rapid diagnostic testing (RDT) is the use of immunochromographic assay with monoclonal antibodies to determine whether a
blood sample contains protein markers specific for malaria. The test
is simple to interpret and a result can be obtained in 5 to 20 minutes.
Thus, use of these tests requires little training. Also, RDT kits are
more transportable than microscopes and require no electricity, thus
making them easier to implement in low-resource or rural settings.10
The same study that found low specificity for routine microscopy
in clinics in Dar es Salaam reported the sensitivity and specificity
of RDT to be 97% and 96.8%, respectively.10 Implementing RDT in
this setting significantly reduced false positive test rates from 43% in
hospitals and 62% in health centers to 6% and 7%, respectively, after
RDT implementation.10 This observed true positive rate was similar
to the rates of parasitemia in febrile patients found in a cross-sectional study of the region conducted at the same time.10 This suggests
that the use of RDT could help to reduce overdiagnosis of malaria
as well as the costs associated with overprescription of antimalarial
drugs. A study conducted in Tanzania looked at the safety, measured
by complication rate, of withholding antimalarial treatment based
on RDT test results in 1000 febrile children with a mean age of 24
months.13 At 7 day follow-up, none of the 603 children who tested
negative for malaria had malaria-related complications, though 4
were admitted to hospitals for other reasons, and 3 of the children
who initially tested negative tested positive 2, 4 or 7 days after initial testing.13 Children are at highest risk for malaria-related death
in this region, and these results suggest that RDT could be a safe and
cost-effective way to diagnose malaria and reduce overuse of antimalarial drugs in this population.5
It needs to be noted that there are several drawbacks to the use
of RDTs. Firstly there are many products available on the market,
which may use different antigens and have different sensitivities to
parasitemia. Histidine-rich protein 2 (HRP2) has been demonstrated
to have P falciparum sensitivity of greater than 95% in several clinical
trials, but results may vary considerably between kits and much lower
sensitivities have been reported for other species.14-19 Assays using P
falciparum lactate dehydrogenase (pLDH) or an aldolase, which are
considered pan-malarial antigens, are also common, but some studies
have reported sensitivities as low as 61% to 76% for non-falciparum
species detection as well as decreasing test performance at lower levels of parasitemia.17-19 This means that asymptomatic carriers could
go undiagnosed and untreated, resulting in continued propagation of
the disease. As well, HRP2-specific assays are prone to false positives,
as HRP-2 may take a long time to clear from the body or may remain

elevated due to the presence of gametocytes, making this assay less
useful for monitoring parasite clearance.20 This means clinicians may
have to use one kit for diagnosis and a second for follow-up. Some of
the observed poor results in trials may have been caused by product
instability at temperatures greater then 30°C or by quality control
issues during manufacturing.14 In order to address quality control issues, the WHO has created an initiative for quality assurance of RDTs
that outlines an appropriate product testing protocol, monitors product quality and provides information to health care providers about
the quality and efficacy of each product.21 This initiative has provided
standards for specificity and sensitivity of RDTs as well as introduced
quality control protocols to product manufacturing and testing, thus
making RDT more robust and reliable in low-resource settings.21

conclusions
Though expert microscopy remains the most sensitive and specific test for malaria diagnosis, the limited availability of appropriate
lab infrastructure and expert microscopists in sub-Saharan Africa reduces its usefulness in this setting. Inaccurate malarial diagnosis may
cause physicians to miss other potentially deadly causes of fever and
may contribute to the overprescription of antimalarial agents and the
evolution of drug-resistant malaria strains. RDTs have been shown
to be both safe and cost-effective in the diagnosis of malaria, are simple to use and interpret and require little training or maintenance of
infrastructure. Thus, RDTs may be a preferable method of malaria
diagnosis in low-resource and rural settings.
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Public health, as today’s physicians have come to understand it,
is a concept that extends beyond the control of infectious disease and
harmful pollutants to encompass social welfare and advocacy.1 The
concept that physicians and healthcare organizations have a professional duty to advocate for social, economic, and political reform as
a method to alleviate population-wide determinants of health dates
back to at least the 1940s, when the newly founded World Health
Organization (WHO) defined health as “a state of complete physical,
mental and social well-being and not merely the absence of disease
or infirmity.”2 The WHO definition continues to exert influence despite the criticisms it has drawn over decades. This definition rightly assumes that health is not merely a negative concept—the mere
absence of disease symptoms—but that it must comprise something
more. In modern medical education, this definition has been interpreted as a professional responsibility for physicians to look beyond
the direct patient interaction and to become advocates and agents
for the reform of economic inequalities, discriminatory social institutions, and cultural prejudices.3,4 In this article, the authors call for a
debate about the merits of this public health paradigm.

the case against it
The approach to healthcare that is implied by the World Health
Organization’s (WHO) definition has won many adherents, yet it
also has its share of critics. Surprisingly, some of the most powerful
arguments that critics have been making since at least the 1970s remain only partially addressed by proponents of the current healthcare paradigm.
There are two fairly straightforward criticisms, which may be
stated briefly.5 In the first case, suggesting that broader social and
economic reform is within the scope of modern medicine may ascribe too much authority to physicians. Physicians are not politicians.
A separate criticism is that such a conception of public health vastly
expands our ordinary notion of “health” to include potentially most
of what we would normally understand to constitute human happiness. Indeed, what human goods, whether individual or social, might
not be understood to fall within a state of physical, mental, and social
well-being that is “complete”? Both criticisms remain weighty objections that must chasten the reformist zeal of any physicians who
claim the authority to take leadership roles in institutional reform as
their professional prerogative. Nevertheless, these two criticisms do
not decisively nor necessarily defeat the social welfare idea of public health. Nothing prevents physicians from informing themselves

and becoming more expert in public policy matters. On the contrary,
well-informed physicians who understand the inherent limitations of
the perspective of their profession could be a valuable voice in public
policy debates. As long as professionals keep in mind that health is
distinct from broader concepts such as subjective happiness, and that
it is only one precondition of a full human life, we will avoid confusion regarding the fundamentals.
Beyond these more or less straightforward criticisms, however, there are more profound philosophical objections that challenge
the current public health paradigm in a more radical way. Several
decades ago, Ivan Ilich argued that by transforming pain, illness,
and death into a set of purely technical problems, to be addressed
over time by medical science, we have made these problems not
more, but less manageable.5 According to Ilich, modern medicine
has sold the public a false bill of goods: for at least a century it has
held out the promise of an ever-increasing lifespan and of the eradication of an increasing number of devastating diseases. This promise has proven to be only an illusion: the diseases we have eradicated (small pox, measles) have been replaced by new ones (cancer,
obesity, mental illness). Yet not only have we replaced one set of
illnesses with another; perhaps more importantly, we have also
rendered ourselves complacent regarding the inevitability of our
mortality. The illusory belief that with sufficient advancement in
medical science we will one day be able to conquer pain and disease has gradually led our society into a perpetual denial of the need
for each one of us to face the inevitability of disease, and ultimately
death. Conversely, according to the conception of health favoured
by Ilich himself,
[h]ealth designates a process of adaptation. It is not the result of instinct (ie, to avoid pain), but of autonomous and
live reaction to an experienced reality. It designates the
ability to adapt to changing environments, to growing up
and to ageing, to healing when damaged, to suffering and
to the peaceful expectation of death. Health embraces the
future as well, and therefore includes anguish and the inner resource to live with it.5
In addition to traditional modes of medical intervention, “welfare, international relief, and development programmes are enlisted
in this struggle” to obscure the true problem of health—the expansive, social welfare idea of public health would rob us of the humane task of coming to terms with our fate as mortal beings.5
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the case for a social welfare idea of public health
Article 27 of the Universal Declaration of Human Rights, adopted by the United Nations General Assembly, states that everyone
has the right to share in scientific and medical advancements, and
their benefits.7 The International Covenant on Economic, Social, and
Cultural Rights includes the right to health as a basic right, and the
definition also includes the right to the social determinants of health,
such as housing and nutritious food, with the understanding that
they contribute significantly to health outcomes.8 This is a key point.
There is considerable evidence to suggest that the process of neoliberal economic policies and globalization has hollowed out the health
systems of the Global South and made the poor ever poorer.2 Increasing privatization and trade reforms have made access to healthcare
difficult, and have also reshaped access to the social determinants of
health, such as food and housing. For instance, neoliberal trade reforms have damaged local food security in the Global South by encouraging a shift to store-bought food away from local food,8 which
in turn has not only resulted in an increase in prices, but also in the
incidence of diabetes and obesity.8
Human rights, and especially a rights-based approach to health,
offer an alternative to neoliberal policies8 in that they eschew
cost-effectiveness when it comes to human life. Instead they posit
that doctors can, and should, advocate for policies that consider the
social determinants of health. Healthcare providers can lessen the
impact of social inequalities, especially since the natural history of
disease encompasses social phenomena.9 For example, tuberculosis
disproportionately affects First Nations, partly due to cramped living
conditions and the poor ventilation found in substandard housing
on reserves, which has risen as a result of a history of governmental
neglect and historical circumstances. Simply treating tuberculosis
in this situation will not address the social determinants of the illness.9 Although Rene Dubos may have expressed doubt in the lack of
training that physicians have in political advocacy, he also mentions
repeatedly throughout his book Mirage of Health that one cannot forget that improvements in socioeconomic conditions since the 19th
century have been the true major cause of the decline in the incidence of communicable diseases in the Western world.10 The reform
movements of the 19th and 20th centuries directly took on the poor
living conditions that lead to such unconscionably high incidences
of diseases, such as tuberculosis and cholera, amongst the working
classes. One of the doctors at the forefront of the reform movement
was none other than Rudolf Virchow, who was a pathologist and civic
and public health reformer. Virchow is famous for having said that
“physicians are the natural attorneys of the poor.”7
Dr Paul Farmer has perhaps been the one health scholar who
has been able to clearly articulate the rationale for a rights-based approach to health, and its demands on physicians. He has been able to
meld liberation theology’s demands for the rights of the poor with
conventional human rights analysis and work, and thus refocus our
attention on social justice and towards the fundamental moral equality of all persons.5,11,12
Dr Farmer’s writings are primarily concerned with the upstream
social determinants of health, specifically with those factors that he
defines as constituting a form of structural violence. Structural violence refers to social structures that stop individuals, groups, and so-

cieties from reaching their full potential.8 It is related to the concept
of structural oppression, which more generally speaks to socioeconomic conditions such as poverty and racism that lead to the violations of people’s civil, political, and economic rights. For instance, although the Canada Health Act guarantees access to healthcare with
no direct nor indirect barriers, the existence of historically underserved populations, such as the First Nations or the lesbian-gay-bisexual-transexual-queer community, give evidence to the fact that in
practice, these groups as well as many others have been effectively
disenfranchised of their right to health.
Structural violence is a powerful concept in understanding the
pathology of society’s ills. It challenges the community of medicine to
understand that although vulnerable populations are offered formal
rights in Canada or abroad, the actual enforcement of those rights
is spotty at best. The concept of structural violence also posits that
even where civil and political rights are equally exercised (freedom
of speech, association, etc), disparities in economic rights, such as a
right to an education, to housing, and to health, affect people on a
more substantive level.6 It is in this vein that Dr Farmer advocates
for approaching the diagnosis and treatment of diseases as a public
good.5 Medical services are not just commodities to be purchased
and delivered—indeed this is the core belief of a rights-based approach to health.
In conclusion, the inextricable link between the natural histories
of diseases and socioeconomic factors, such as race and poverty, demand that physicians advocate and work to ameliorate those factors
that continue to perpetuate and maintain disease. Physicians should
certainly understand the lack of training in politics that most of them
have, as well as be humble about their ability to significantly treat the
socioeconomic determinants of health.
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what are the millennium developmental goals?
In September 2000, over 150 world leaders gathered in New
York City at the United Nations (UN) Headquarters for an event
called the Millennium Summit. Its purpose was to discuss what the
role of the UN would be in the 21st century. As a product of these
discussions, 189 nations ratified the United Nations Millennium
Declaration, which included eight broad Millennium Development
Goals (MDGs) that lay out numerous specific quantitative targets
for improvement of various health and economic indicators in developing nations of the world.
With less than a year to go before the 2015 deadline on most of
these goals, progress varies considerably. We examined how several
global health-related goals were progressing toward their targets:
specifically Goal 6, regarding the halting of Human Immunodeficiency Virus (HIV) spread and universal access to treatment for the
disease, as well as Goal 4, regarding the reduction of child mortality.

goal 6: combatting hiv/aids
Since the Millennium Declaration was signed, global funding
devoted to combatting HIV has increased over tenfold, from US
$1.6 billion in 2001 to over US $16 billion annually in 2010, resulting
in a significant reduction in global HIV burden.9 The development
and mass production of HIV-fighting drugs at substantially lowered
prices compared to those seen in developed nations has reduced
the worldwide number of deaths from HIV by 25% in just the past 6
years.7 An especially effective strategy in combatting HIV has been
the formation of the Medicines Patent Pool, a UN initiative which
allows the production of generic HIV, malaria, and tuberculosis
pharmaceuticals in high-risk countries while waiving or discounting the drugs’ expensive patent fees. In 2000, the global average
cost of HIV treatment neared US $10 000 annually; however, with
the advent of fixed-dose combination pills (a single pill containing
multiple HIV medications) and the creation of the Medicines Patent Pool, this annual cost has dropped to a median of US $137 per
person,10 and under US $70 in some nations.11 This represents an
incredible 99% reduction in price in only a decade.
Despite these breakthroughs, as of 2011 only 8 million (55%) of
the approximately 15 million people in developing countries who
require HIV treatment actually receive it—far from the UN’s goal of
universal access to treatment.7 This still marks a massive improvement over the past decade, where less than 400 000 people received
treatment in 2002.10 In developing nations, access to treatment has
been steadily increasing, to the current high of 1.5 million newly
treated people per year. This improvement means that the number
of people in developing nations receiving HIV treatment will hit an
astounding 15 million by 2015—nearly double the figures from 2011,
and very close to the UN’s overall goal.7

The annual HIV infection rate has decreased over 21% globally since the creation of the MDGs, yet still more can be done. The
greatest effects on global HIV burden can be exerted by focusing
more attention on the highest-risk area: sub-Saharan Africa. Of the
2.5 million people in the world that became infected with HIV in
2011, 1.8 million (approximately 70%) were in sub-Saharan Africa,
where the current rate of infection nears an unbelievable 1 in 20.
The simplest, most cost effective way to curb the spread of HIV
in this region (and globally) is by promoting education about modes
of viral transmission and methods of safe sex, as well as distributing condoms. Research indicates that the introduction of safe-sex
education programs such as Asia’s 100% Condom Use Programme
has been extremely successful, more than doubling the use of condoms in Cambodia and preventing 6 million HIV infections over 15
years in the handful of Asian countries that adopted the program.12
However, currently only 30% to 35% of sub-Saharan Africans are
educated on how HIV is transmitted, up barely 5% from a decade
ago. Similarly, the use of condoms has increased only 5% to 10% in
that time period, now hovering at around 40%.7
One of several reasons for this failure to implement change in
sub-Saharan Africa pertains to the quality of education in these nations. For example, sub-Saharan African populations comprise over
half of the world’s out-of-school children, with enrollment rates at
approximately 77%, and over one quarter of these students drop out
before reaching the end of primary school education. Literacy rates
reflect these disparities, as only 65% of women and 75% of men are
able to read and write, representing less than 5% improvement in
the last 20 years.7 Addressing this sizeable barrier to sexual education lies under the purview of another of the MDGs (Goal 2, universal primary education), and it may be that progress must be made
there before sexual education can become more prevalent and an
effective HIV-deterrent in sub-Saharan Africa.

goal 4: reduce child mortality
Another important MDG is Goal 4, reducing child mortality.
The original target was to reduce the mortality rate of children
under 5 by two-thirds by 2015. Not surprisingly, populations more
likely to experience high rates of child mortality tend to be the
poorest and most marginalized,1 highlighting the relationship between economic wellbeing and health outcomes.
About 40.3% of deaths among children under 5 years of age
occurred in neonates, with preterm-birth complications and intrapartum-related events as the leading causes. Precluding neonatal
deaths, the leading causes of child mortality are pneumonia, diarrhea, and malaria.2
Deconstructing these causes of mortality further necessitates
the discussion of social determinants of health. Generally, it is the
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socioeconomically disadvantaged populations of sub-Saharan Africa and South Asia that bear the majority of child mortality burden.
Living in remote rural areas, these populations often have limited
access to health services and social supports that are known contributors to health. Still, there is also an appreciable burden borne
by poor urbanites. It has been reported that factors such as hygiene,
overcrowding, and air and water quality may be even worse in urban areas, eliminating the notion of an “urban advantage”.3,4
The link between poverty and undernutrition has been well
recognized. It has been estimated that about 45% of all child deaths
are associated with undernutrition. Rates of stunting, wasting, and
fetal growth restriction are especially high in sub-Saharan Africa
and Asia, and are slow to decrease. Compounding the problem is
increasing food prices, with global food price indices reaching peak
levels in recent years.3
Fortunately, there has been progress. In 1990, the mortality rate
for children worldwide was 90 deaths per 1000 live births. As of
early 2014, this figure has dropped by 48% to 48 deaths per 1000 live
births.1 Africa in particular has seen some of the greatest decreases
in child mortality ever recorded. Of 20 African countries in which
the World Bank has conducted detailed surveys of living conditions
since 2005, 16 have recorded falling rates of child mortality. Additionally, 12 nations have had rates of reduction of 4.4% or greater,
putting them well on their way to meeting the 2015 goal. These dramatic reductions in child mortality have crossed geographical and
cultural boundaries, with countries all across the continent, Christian and Muslim, cutting child mortality rates. South Asia, with the
second-highest child mortality rate in the world, has seen similar
successes.5
Broad economic growth as well as public health interventions
have been the most important strategies for combatting child mortality.6 In Chad, a UNICEF (United Nations International Children’s Emergency Fund)-sponsored immunization program has
greatly reduced under-5 mortality. Similarly, in Cambodia, measles
immunization increased by 71% between 2000 and 2012, and with
support from the World Health Organization (WHO) in reaching
communities that were missing out, Cambodia reported no measles
cases in 2012. In India and Nigeria, increasing healthcare access
to rural communities and women and children, respectively, have
been effective strategies.1
Even with great progress, many organizations cite that the rate
of improvement in many countries is still not high enough to meet
goal 4 by the 2015 deadline. In the UN’s 2013 progress chart, it is
reported that sub-Saharan Africa, Southern Asia, Oceania, the Caucasus and Central Asia still have insufficient progress to meet the
2015 deadline despite vast improvements since 1990.7 Becoming a
recent priority is neonatal death, which was cited earlier to comprise a large proportion of under-5 deaths. Troublingly, while the
rate of child mortality has decreased rapidly since 1990, the rate of
neonatal death has been much slower to do so and now comprises
an even larger proportion of under-5 deaths.
A more intensive effort is now being made to reduce neonatal
death, as evidenced by a global decrease in neonatal mortality, but
novel strategies must be employed as the requirements to reduce
neonatal mortality differ from those needed to address under-5

mortality. One cost-effective strategy that is suggested in the 2013
UN report is that of postnatal home visits to promote healthy behaviours such as breastfeeding and clean cord care.8
Although not all targets will be met by the self-imposed 2015
deadline, it is undisputable that the pursuit of the Millennium Development Goals has had a vastly positive impact on vulnerable
populations across the globe. As we progress further into the 21st
century, one can only hope that the current promising trends regarding socioeconomic progress and the promotion of global health
will continue, and that developed nations will only heighten their
role in helping this change endure.
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abstract
Perhaps the greatest medical advancement in history was the
development of the vaccine. While previously helpless to stop the
spread of deadly infectious diseases, humanity has since harnessed
the power of vaccination and decreased the incidence of infectious
disease across the globe. Smallpox was the first disease to be eradicated—the greatest of our triumphs. This success was due to the
global coordinated effort of the Intensified Smallpox Eradication
Program. Presently, measles is the top cause of vaccine-preventable death in the world, and despite enormous vaccination efforts,
eradication is still distant. This is due in part to the antivaccination
movement, which was fueled by an article by Wakefield, published
in the Lancet in 1998. The future of vaccination is an ambitious and
unclear one—with tremendous financial support and involvement,
the Global Vaccine Action Plan (GVAP) aims to eliminate vaccine
preventable illness within what they call the “Decade of Vaccines”.

past: smallpox
The most illustrative example of the power of vaccination to
alter disease prevalence around the world is undoubtedly the eradication of smallpox. The earliest signs of smallpox were found in
mummified Egyptian remains approximately 3000 years old. It
existed throughout China and India, was established in Europe
during the Crusades, and was spread to the Caribbean and Americas following European colonization.1
Smallpox was an exclusively human disease (there is no animal
reservoir, nor does it exist in the environment), meaning that in order to propagate, the disease had to be transferred between human
hosts; this factor made the disease amenable to eradication.1 Nonetheless, in its time, smallpox was a disease of historical significance.
By the end of the 18th century, smallpox had killed approximately
400 000 people each year in Europe—notably, 5 monarchs—and
caused one-third of all blindness. During the 20th century, about
500 million people died from smallpox worldwide, particularly as a
result of large epidemics in Asia, Africa, and South America.2,3
While Dr Edward Jenner is commonly considered the father
of vaccination, his smallpox vaccine was pre-dated by the practice of variolation, in which susceptible individuals had their skin
scratched and the scratches inoculated with material from smallpox
lesions. Variolation resulted in mortality in about 2% of cases (lower than the rate of natural infection) and was practiced throughout Asia and Africa for centuries. In 1796, Jenner began inoculating
susceptible individuals with cowpox as a vaccine for smallpox—he
called his inoculum varioale vaccine (from the Latin, vacca, for
“cow”), a term which was redefined by Louis Pasteur to mean any
protective inoculation. While these early attempts slowed the disease, they were not responsible for its eradication.2

The true potential for vaccination was fully realized with the
Intensified Smallpox Eradication Program, initiated in 1967 after
the success of mass vaccination in Western Europe, North America, Japan, and several other developed nations. In 1964, the World
Health Organization (WHO) recommended vaccination of 100%
of the population, and in 1966 the WHO allocated US $2.4 million
from their budget to carry out this recommendation. Several breakthroughs proved key to the successful eradication of the disease,
including the development of the quality-controlled, heat-stable,
freeze-dried vaccine, and its highly efficient partner, the bifurcated
needle, both of which enhanced the delivery, efficiency, and cost-effectiveness of the vaccine. Specific surveillance strategies were developed to help detect and report smallpox; this was particularly
critical for eradication in endemic areas with poor health services
since it allowed outbreaks to be rapidly identified and isolated.1,4
In 1977, the last naturally occurring case of smallpox was found
in Somalia. Two years later, the WHO declared worldwide eradication of smallpox on December 9, 1979. As a result of global eradication—which cost US $300 million—US $1 billion are saved annually.4
More than a lesson in history, the eradication of smallpox can
act as proof of the power of vaccination to save both lives and money, and its tale offers many lessons that can be applied to current
and future diseases.

present: measles
Measles is among the top causes of death in developing nations,
and is the top vaccine-preventable killer with a death toll around
138 000 in 2010.5 The WHO reports that it is moving towards eradication of the disease less aggressively than with the eradication of
smallpox; in 2010, the WHO agreed on a target of 95% reduction
in measles mortality by 2015 as the next step towards its eventual
eradication.6 Indeed the prevalence of measles has been drastically reduced since the release of the vaccine; while previously 3 to
4 million people in the United States were infected each year, and
400 to 500 died, as of 2012, only 55 cases of measles were reported
in the United States. This represents a greater than 99% reduction,
but unfortunately is not typical of all countries. In underdeveloped
nations, where health care is poor, vaccine coverage for measles
was approximately 15% lower than developed nations in 2010.7-9
Thus, successful eradication and control of disease is dependent on
the addressing of logistical needs specific to underdeveloped areas.
The WHO has some strategies for overcoming this lack of coverage,
such as the incorporation of vaccine programmes focused on eradication into national health programmes.6
A major setback in the battle against measles has been the recent antimeasles vaccine movement in developed countries. This
controversy began initially in 1998 with the publication in the Lancet
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of research that demonstrated a link between the measles, mumps,
and rubella (MMR) vaccine and gastrointestinal disease and developmental regression (notably autism spectrum disorder) in children.10 This article sparked uproar in the medical community, with
numerous editorials appearing in the Lancet and several independent investigations looking at the methods and circumstances surrounding the research. The article was partially retracted in 2004
and completely retracted in 2010 by the Lancet, due to proof and admissions by some of the authors that the research was fraudulent.11
An investigative journalist, Brian Deer, discovered undeclared conflicts of interest, manipulation and fabrication of evidence, and the
violation of several ethical codes on the part of the primary author,
Andrew Wakefield, resulting in the loss of his license to practice
medicine in the United Kingdom.12-14 Despite the retraction of the
article and the exposure of Wakefield’s research as fraudulent, there
were immediate population consequences of underimmunization.
For example, between December 1999 and July 2000, an outbreak
of measles occurred in Ireland, resulting in 111 hospitalized children
and 3 deaths; this outbreak was the result of suboptimal (< 70%) vaccination following the Wakefield article.15
Even now, the antivaccination movement challenges the MMR
and other vaccines, threatening eradication efforts being undertaken
worldwide. One reason the movement is still alive is due to the work
of semicelebrity figureheads, such as Jenny McCarthy, an American
model, and Jim Carrey, a Canadian actor, who garner media attention
for the cause through outlets such as Oprah, Larry King Live, and
Good Morning America.16 In fact, Jenny McCarthy has stimulated
the American antivaccination movement to such an extent that an
online counter was made at jennymccarthybodycount.com to record
approximately how many preventable illnesses and deaths resulted
from her endorsement of the movement.17 Aside from following the
advice of these figureheads, parents give many reasons for refusing
vaccination, including religious objection, complementary or alternative medicine preference, doubts about vaccine safety, and personal ignorance.18 Ultimately, to win the battle against measles and other
vaccine preventable illnesses both at home and abroad, public trust
in vaccination must be re-established.

future: global vaccine action plan (gvap)
In May 2012, the World Health Assembly developed a framework meant to provide “immunization to all people, regardless of
where they are born, who they are, or where they live.” This was
the Global Vaccine Action Plan (GVAP), a vaccination strategy for
global health that receives major contributions from the WHO,
the US National Institute of Allergies and Infectious Diseases, the
United Nations Children’s Fund (UNICEF), and the GAVI Alliance
(formerly the Global Alliance for Vaccines and Immunization),
a branch of the Bill & Melinda Gates Foundation. This plan sets a
deadline of 2020—the end of the Decade of Vaccines.19 The goal is
to eliminate vaccine preventable illness within the decade.20 The
GVAP embraces 6 strategic objectives:
1. All countries commit to immunization as a priority: this
requires countries to pass legislation providing a budget for
immunization, monitoring, and reporting, and to set specific

2.

3.

4.

5.

6.

morbidity and mortality reduction targets. It also asks that
countries continue to act as immunization advocates for their
own populations, and for other countries.
Individuals and communities understand the value of vaccines
and demand immunization as both their right and responsibility: this asks countries to promote vaccination through
education, and to create incentives for households and health
workers to receive immunizations. It emphasizes particularly
the need for professionals trained to address vaccine hesitancy
and respond to reports of adverse events in order to maintain
public trust of vaccines.
The benefits of immunization are equitably extended to all
people: this asks countries to reach out to underserved or
marginalized groups, and to develop immunization strategies
specifically tailored to the needs of each particular group. It
encourages the use of existing health care systems and professionals to track individual immunization histories, and aims to
develop new approaches to engage urban and peri-urban areas.
Strong immunization systems are an integral part of a
well-functioning health system: this asks countries to focus
on eradication, elimination and integration of immunization
into existing national health programs. It also encourages the
improvement of monitoring and surveillance systems through
better data collection and analysis, and of the availability and
reliability of vaccines through increased cold storage capacity.
Immunization programmes have sustainable access to predictable funding, quality supply, and innovative technologies: this
seeks to increase funding toward immunization, especially in
low- and middle-income countries, and to increase the affordability of vaccination.
Country, regional, and global research and development innovations maximize the benefits of immunization: this encourages the development of vaccine innovations such as nonsyringe
delivery, thermostable vaccines, and more affordable manufacturing facilities, and also research into fundamental knowledge
about vaccine-preventable illnesses, including epidemiology,
behavior in the body, and response to vaccination efforts.21

The GVAP is the largest concerted effort to immunize the
world’s population against vaccine preventable diseases. Though
these efforts are well underway, whether or not the goal of the Decade of Vaccines will be reached remains unclear. With 6 years remaining, anything could happen. Learning from our previous successes with smallpox, vaccine preventable diseases can surely be
made obsolete. Though it may require dedication, innovation, and
education in equal measure, the demise of vaccine preventable diseases is on the horizon.
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abstract
This article explores how international medical tourism,
the acquisition of medical services in another country for various reasons, has changed from ancient times, to Renaissance and
post-Renaissance Europe, and to the present. It examines the sociocultural, medical, and environmental factors driving medical
tourism, as well as how medical tourism has in turn influenced
humanity. We take a look at the current trends in medical tourism with examples of the most popular destination countries. Finally, we will address potential future developments in medical
tourism and the associated issues.

introduction
The term “medical tourism” conjures images of patients flying
across the world to acquire a tummy tuck or heart transplant, procedures theoretically available in their own country, yet inaccessible
due to long wait times or unbearable costs. However, medical tourism has occurred in a much broader way, to different groups of people for a variety of reasons. In fact, for the vast majority of human history, the desire to travel for the sake of health care was driven by the
simple fact that the health service sought after did not exist at home.

medical tourism in the ancient times
Before the advent of complex technology in medicine, much of
medical tourism consisted of mineral thermal springs and baths.1
As historian George Weisz states, “True mineral waters were very
much connected with place and were frequently thought to lose
their therapeutic powers if they were moved to another location.”2
Perhaps during no time in history was this statement more true than
the ancient times when many baths were considered sacred. When
the Greek empire was at the height of its power, tourists from across
the world flocked to its healing temples.1 These included the Asclepia Temples, constructed in honour of the god of medicine Asclepius,
as well as the Sanctuary of Zeus in Olympia and the Temple of Delphi. Some of these temples also contained gymnasiums and places
of prayer. Aside from commercial purposes and the demonstration
of Greece as a superpower, such sacred healing centers undoubtedly
promoted the popularity of the deities that they represented.

medical tourism from the renaissance to the
19th century
The use of mineral waters, often as a component of high-altitude “climatic resorts”, as a mainstay of healing and prophylaxis remained popular well into the 19th century, although its association
with religion lessened. Hydrotherapy was thought to be beneficial
in a wide range of ailments such as pimples, gonorrhea, rheumatic
diseases, and nervous conditions.3

In 1326, iron-rich hot springs were discovered near Ville d’Eaux
(Town of Waters), France, making the little village famous. It was
here that the word spa, derived from the Roman phrase salude per
aqua (“health through waters”), was first used. The spa of Ville
d’Eaux would later serve as host to historical giants such as Peter the
Great and Victor Hugo.3
In the 1720s, the English city of Bath was one of the richest
and most technologically advanced, being the first city in England
to receive a covered sewage system. This dramatically advanced its
spa tourism industry, and the economic benefits to the city were
enormous. These included paved roads, streetlights, hotels, and
beautified restaurants.1
With the widespread popularity of spas, it is not surprising that
the financial stakes attached to them became increasingly high, with
competition between spas. Many spas added other services, such as
walks, music, dance, theatre, socializing, and gambling to their repertoire in order to attract customers. As technology became more advanced, various methods of delivering water healing were offered in
addition to bathing, including vaporization, showering, and more. In
France, an entire academic discipline on “medicalized thermalism”
was established to promote the spa industry by adorning it with a
“scientific” appearance. Funded directly by the spa industry, a large
body of literature was produced on the basic chemistry of spa healing
and the potential benefits it exerts on human health. Such research
proved to be so convincing that following World War II, French spas
obtained reimbursement from the social insurance system. Naturally,
as spas became more touristic and commercial, suspicions concerning whether they were truly dedicated to the promotion of health began to arise in the medical community.2
Furthermore, as advances in medical sciences during the 20th
century produced more effective treatments, interest in spa healing
declined. Previous basic science research on spas was discarded as
academic attention turned more towards clinical trials. This signalled
the end of the spa industry, an industry that existed since the dawn of
mankind, as a provider of medical therapy. Many spas consequently
left the medical business in search of other opportunities. Some began to advertise themselves as alternative therapy (which needs not
to be shown as medically effective). Others moved into the wellness
business, complementing mineral waters with other modalities such
as perfumed baths, facials, massage, and physiotherapy.2

medical tourism in the 20th century
Until the late 20th century, the notion of medical tourism remained within the realm of patients migrating to other countries in
pursuit of health care not available domestically. Hence, for a lengthy
time the United States maintained its status as a popular destination,
due to its rapid technological advances in medical care.4 Some ex-
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ceptions to this rule existed, such as the revived interest in yoga and
Ayurvedic medicine in India with the onset of the flower child movement in the United States and the United Kingdom.1
In the 1980s and 1990s, Cuba initiated programs for foreigners seeking eye, heart, and cosmetic procedures.1 These programs
were cheaper and involved shorter wait times than the equivalent
in the foreigners’ own countries. Other Caribbean countries, such
as Jamaica, Barbados, and Puerto Rico, followed suit.4 Each country
established its own niche in the medical field in order to minimize
competition. Jamaica specialized in plastic surgery, Barbados infertility, and Puerto Rico cardiovascular surgery, orthopedic surgery,
neurology, and oncology. These programs were largely geared towards patients from North America and Europe.
The year of 1997 marked the beginning of the Asian economic crisis.6 Among its many coping mechanisms, Thailand invested
heavily in a medical tourism industry for foreigners hoping to obtain affordable access to plastic surgery. It also offered sex-change
operations with looser presurgical psychological requirements than
those in Western countries.7 Furthermore, it established touristic
medical centers, such as the Bumrungrad International Hospital,
featuring interpreters and an airline ticket counter.
During this period of time, many other Asian and Latin countries founded their own touristic medical programs in the hope of
attracting foreigners from Western countries desiring to circumvent lengthy wait times, formidable costs, and convoluted legal restrictions. Westerners, especially those seeking reproductive health
treatments, can also use these oversea opportunities to maintain
their social privacy. Initially such options were only available to
wealthy Westerners able to afford the additional costs of travel
and luxurious accommodations, but as the trend progressed, middle-class citizens were also able to take advantage of these programs.8 Medical tourism as we know it was now truly underway,
and as expected, it carried with it both benefits and drawbacks.
Proponents argue that medical tourism, aside from improving availability of health care, also promotes patient choice, fosters
global competition, places pressure on expensive health care facilities to lower prices, and drives social and economic development.8
The last point can be clearly seen in Cuba, where medical tourism
is a governmental program and revenues generated used to fund its
own public health care system.4
Critics attack medical tourism’s role in furthering the divide between social classes, with the wealthy possessing more opportunities
and higher-quality opportunities than the less well off.9 This applies
not only to tourists, but also to residents of the destination countries
themselves. Many concerns have been raised on whether destination
countries are diverting medical resources from serving their own
population to the tourism industry.4,7,10 This is especially a problem
in countries where medical tourism is a private business.
As well, there are always concerns regarding the quality of care
received in the destination countries.9 Furthermore, legislation and
ethical policies differ internationally. Consequently, patients travelling to international clinics may not be fully informed of the risks and
benefits of their treatments, and may find it difficult to obtain legal
redress if harm results.11 To address issues of quality, the Joint Commission International (JCI), an accreditation body for international

medical institutions, was established in 1997.6,12,14 However, this has
the potential of furthering inequalities in the health care systems in
destination countries, where the higher-income medical tourism physicians would be able to provide higher-quality care than those serving
the local population. As well, tackling the problem of quality may not
solve the disadvantage concerning continuity of care.9 Some patients
return to their home countries without any documentation regarding
the care they received abroad, making it difficult for their physicians to
provide appropriate care in the case of complications. As an example,
Canadian data from 1998 to 2005 revealed that 22 Canadians received
transplants internationally. One third of these patients had no records
upon returning, and complications included 52% with opportunistic
infections, 38% with pyelonephritis (including multidrug-resistant
Escherichia coli), and 27% with systemic sepsis. Compared with Canadians who received transplants at home, inferior graft survival at 3
years was shown for patients with international transplants (98% and
86% survival for biologically-related and emotionally-related donors in
Canada, respectively, versus 62% for international transplants).15

current and future trends in medical tourism
Currently, 28 countries across North America, South America, Asia, and Europe market their medical services internationally.
More than 375 hospitals in 47 countries in facilities across Europe,
the Middle East, Asia, and South America have been accredited by
the JCI, and there are 12 million medical tourists globally. Although
the United States is still the most common destination for Canadian
medical tourists, there are a small number of Canadians traveling
into developing nations for health care. Medical tourism brokerages
exist in Canada, with at least 15 companies acting as middlemen in
organizing hospitals, physicians, flights, and hotel reservations for
Canadians seeking to receive health care abroad. However, these
agencies are not required to verify credentials or licensing of facilities or physicians.12
In 2006, the American Medical Association issued a new set of
guidelines listing certain factors that patients should carefully consider when entertaining the idea of medical tourism.16 This was also
the year when the American insurance company Blue Ridge Paper
Products, Inc introduced a medical tourism incentive into its employee benefit plan.7 Since then, many insurance plans and brokerage
companies have been founded to capitalize on this increasingly popular and lower-cost health care option. Unfortunately, the paperwork
can be extremely complicated, deterring some patients from consulting these companies.17 Certain companies link family physicians to
specialists in foreign countries as a way of maximizing continuity of
care.9 However, family physicians in the Western world should not
automatically assume that this service has been provided, and should
take medical tourism into account when working with any patient.
The 21st century is expected to see an expansion in medical
tourism as the demand for health care in Western countries surpasses the capacity that these countries are able to provide.17 Both
advantages and drawbacks can stem from this rapidly growing phenomenon, and as health care providers it is important to be able to
counsel and manage patients who have pursued or who are considering to pursue this seemingly attractive option so that hopefully,
the advantages can outweigh the drawbacks.
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background of tsunami
On the morning of December 26, 2004, an earthquake shook
the west coast of Sumatra, causing a tsunami that inundated coastal
communities with waves up to 30 meters high. Indonesia was the
hardest-hit country, followed by Sri Lanka, India and Thailand. It
was one of the deadliest natural disasters in recorded history; with
a magnitude of 9.1, the earthquake was the third largest ever recorded on a seismograph. The earthquake caused the entire planet to
vibrate as much as one centimetre and triggered other earthquakes
as far away as Alaska.1
The tsunami killed over 275 000 people in 14 countries, left tens
of thousands of people injured and rendered over 10 million people
homeless and displaced. Measured in casualties, this was the single
deadliest tsunami in recorded history.2 Children accounted for more
than a third of those killed because “they weren’t strong enough to
hold on to fixtures or trees to resist the surging tidal waves”3 and up
to 4 times more women than men perished in some regions because
they were waiting on beaches for fishermen to return.4 In addition,
up to 9000 foreign tourists staying in seaside resorts during the holiday travel season were among the dead or missing.5

damage of tsunami to health care services
At a time where thousands of patients desperately needed medical attention, many of the health care sectors in the affected countries were too badly crippled to adequately meet the demand. For
example, the tsunami destroyed 53 of the 244 health clinics in Indonesia, the country closest to the epicenter. In a country already low in
numbers of doctors and nurses, it was estimated that as many as 691
health personnel were either confirmed dead or missing.6 Also disrupted were telephone lines, transportation, clean water supply and
electricity,6 constituting a major blow to the health care system. In
the Maldives, where 80% of the land is less than one meter above sea
level,7 many clinics and hospitals were flooded and lost their medical
records and equipment.8 Moreover, the island health care system depended heavily on expatriate physicians and nurses, many of whom
left to go back to their native countries to be with family.8 In Sri Lanka, many of the patients who required orthopedic surgery had to be
transferred to the inland capital of Colombo not only because the
seaside hospitals were in poor condition that made large procedures
risky to perform, but also because hospitals ran out of equipment.9

relief efforts

a. local (internal) cooperation
One of the efforts that received most praise was the coordination of relief that occurred within each of the affected nations.6 For
example, one of the more complex challenges that arose immediately after the storm was the handling of the large number of dead

bodies. In Indonesia alone, reports indicated that there were over
100 000 dead bodies spread over the coastal sea line, which rapidly
overwhelmed mortuary space.6 Efforts were further complicated
in some cases by “pressures from the media and families of tourists who arrived seeking some type of closure on their relatives.”10
Consequently, teams of health care personnel, police, military, relief
workers and volunteers worked quickly and closely to dig out and
handle large numbers of dead bodies in makeshift graves.8
Moreover, in response to the initial wave of patients, some countries were able to manage the influx by transferring them to hospitals
in unaffected regions. For example, hospitals in the Maldives were
able to coordinate and provide patient evacuations through a ferry and air charter system.10 Thailand also had pre-existing disaster
management plans and was able to quickly provide emergency food,
water and medical supplies to the worst-affected areas.11
While experiences of individuals left homeless by the storm varied between and within areas, reports indicate that in Sri Lanka, for
example, friends and families were largely receptive to those affected, while schools and other public buildings in the Maldives were
opened to accommodate large numbers of people left homeless.8
B.

foreign (external) cooperation between governmental
groups, non-governmental organizations and
military forces

The scale of the tsunami was matched by an outpouring of material assistance. In total, US $14 billion dollars in aid was pledged.2
Monetary aid aside, much of the relief was due to the rapid arrival of
external emergency medical assistance. In total, the humanitarian
relief effort brought together over 130 governmental and non-governmental (NGO) organizations from all over the world within the
first 2 weeks that helped to deploy emergency health care staff.10
One of the greatest fears of the relief efforts was the possibility of epidemics due to the high population density and tropical
climate of the affected areas.2 Fortunately, these problems were
minimized due to the quick provision of fresh drinking water and
sanitation facilities. The drinking water response was described as
“timely, effective and comprehensive” and involved the combined
efforts of United Nations agencies, NGOs, defense forces, private
companies and individual volunteers.12
Military efforts also provided indispensable relief. In Indonesia,
foreign militaries worked alongside national militaries and civilian
relief teams to reach people in outlying areas that had been cut off.8
In the Maldives, the military provided supplies and constructed temporary shelters.8 In many cases, there was cooperation between relief units of foreign militaries and other international organizations
to provide initial aid and assist in reconstruction efforts.13
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c. canada’s role in relief efforts
Canadian International Development Agency
The Canadian International Development Agency (CIDA) was
founded in 1968 to facilitate aid to developing countries.14 In 2004
it played a key role in coordinating and administering the financial
aid from the Canadian government and Canadian public in areas
affected by the tsunami: $425 million of support was given by the
Canadian Government and $230 million was raised by the Canadian public.15 CIDA also coordinated humanitarian efforts through
working with Foreign Affairs Canada, Canadian Public Health
Agency, United Nations, the Red Cross, Oxfam and other major aid
agencies.15 In 2013, CIDA merged with the Department of Foreign
and International Affairs to become the Department of Foreign Affairs, Trade and Development (DFATD).14
The Canadian Red Cross
The Canadian Red Cross is a charity organization that engages in humanitarian projects and disaster response worldwide. Its
workers provided aid to Indonesia, Sri Lanka, India and the Maldives using different types of emergency response units:16,17
• Basic Health Care Unit		
• Responsible for outpatient clinic services, maternal-child
health and uncomplicated deliveries and immunization
and nutritional surveillance
• Involves local health care workers, expatriate doctors
and nurses and interpreters
• Referral Hospital 			
• Functions as a first-level field hospital and can provide
care for up to 250 000 people
• Provides specialist services such as traumatology, obstetrics and pediatrics
• Rapid Deployment Hospital
• Can be established within 48 hours
• Focuses on triage, first aid, limited medical or surgical
care and medical transport
Other emergency response units used by the Red Cross are involved in logistics, communications, water provision and sanitation
efforts.17
It should be noted that the Canadian Red Cross in Sri Lanka
also made an effort to provide psychosocial support for traumatized
communities.18 Following the disaster, the Canadian Red Cross
based in Sri Lanka launched training for 49 community health
workers in psychosocial assistance.18 Their aim was to lessen the
impact or onset of depression, insomnia and alcohol abuse and to
prevent suicide.18
Disaster Assistance Response Team
The disaster assistance response team (DART) is made up of
200 Canadian Forces personnel. The purpose of DART is to provide
emergency relief until international aid agencies are able to provide
long-term support.19,20 The DART medical platoon treats minor injuries, leads preventative medicine initiatives and provides limited obstetrics; meanwhile, the engineering troop repairs roads and

electrical systems, constructs temporary housing and operates water supply systems.19 The remaining members of DART assist in water sanitation, communication and security efforts.19 On January 2,
2005 Prime Minister Paul Martin announced that DART would be
deployed to Sri Lanka.19,20 During their mission in Sri Lanka, DART
was able to treat more than 7620 people and produce approximately 3.5 million litres of drinking water.19

challenges related to cooperative relief efforts
Because the 2004 Indian Ocean tsunami was such a large-scale
disaster that drew such substantial numbers of relief agencies, the
coordination of humanitarian operations posed many challenges.10
Many local ministries of health lacked suitable staff to coordinate
the arrival and work of so many people, equipment and donations.10
Separately, some of the foreign aid groups were also reluctant to
“coordinate their approaches among themselves or with local staff”
and were also “not familiar with the cultures involved, did not speak
the languages of the people […] and were insensitive to the ways in
which people in different societies respond to crisis.”8,10 Agencies
may have also been competing for funds and visibility which also
limited their eagerness to coordinate.10
There were other cases where lack of communication and coordination contributed to resources being either duplicated or directly wasted. In one case, relief workers were sent to areas where
help was not needed: “one wealthy foreign nation dispatched a
team of 10 professionals to Thailand, but they were told there was
nothing for them to do.”11 There were also reports of inappropriate
drugs donated, including drugs that were not relevant to the emergency situation or drugs that were already expired. In fact, approximately 150 metric tons of unusable medications were destroyed in
Colombo alone, the capital city of Sri Lanka.22

conclusion
The 2004 tsunami resulted in an immeasurable loss that challenged the health care systems in Indonesia, Sri Lanka, India and
Thailand and pushed the international community to provide relief. Local and foreign health care workers came together to adjust
to the high volume of injuries and displaced individuals. Sanitation
and preventive medicine were critical in preventing epidemics and
further loss of life.
Through reflecting on the events of the 2004 tsunami one can
distill valuable insights. Following a crisis, coordination is paramount to ensure resources are used to their fullest potential. Furthermore, nonmedical professionals such as administrators, media
personnel, engineers, translators, military troops and grief counsellors each have a significant role to play in relief efforts. Continuous teamwork in the aftermath of the 2004 tsunami smoothened
the transition of affected countries from emergency measures into
long-term recovery efforts.
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background

administration

Malnutrition is one of the most serious problems facing the
world today. The World Health Organization (WHO) estimates that
a third of all children deaths can be attributed to malnutrition. The
primary cause of malnutrition for the majority of the world’s population is undernourishment: around 2 billion people are estimated to
be malnourished globally.1
Malnutrition impairs the body’s ability to perform a number of
functions, including mounting immune responses to pathological
insults as well as recovering from those insults. This is particularly
evident in acutely malnourished children, whose inability to respond
to pathogens is largely responsible for the high case fatality rate of
many childhood diseases in developing countries. Additionally, malnutrition leads to failure to grow and thrive, developmental delays
and illness, among other adverse effects on the body.
For many intergovernmental and nonprofit organizations, responding to malnutrition can be a difficult challenge. Providing a
compact, affordable and nutritious supplement that is resistant to
bacterial contamination is ideal, but often proves to be difficult in
famine-stricken rural regions. In recent years, the development of
ready-to-use therapeutic foods (RUTFs) has been hailed as a milestone in the fight against malnutrition. RUTFs are targeted primarily at acutely malnourished children in the age-range 6 to 59 months
with a sufficient appetite, but who do not suffer severe medical complications.2 RUTFs are a significant source of caloric intake and micronutrients. They are aimed at restoring a healthy weight to malnourished children and decreasing the incidence of wasting and
severe wasting.

An important advantage of RUTFs is their suitability for use by
community members and nonmedically trained staff. Oftentimes,
they are used in remote locations beyond the reach of the healthcare systems of famine-stricken countries. To that end, research on
RUTFs has focused on their effectiveness in community-based and
home-based administration settings. The target population of these
interventions are acutely malnourished children. Of particular concern in this segment are children with acute or chronic diseases.
Malnourishment’s negative impact on the immune system adds to
mortality and morbidity associated with those diseases.
Community-based administration has been studied in a number of countries, with several positive results reported. For instance,
research on the use of RUTFs in Malawi during the 2006 famine
showed promising results. In one study of around 800 malnourished
children in remote regions, 94% recovered healthy weight after only
8 weeks of RUTF supplementation, with a mean body weight gain
of 2.7 g/kg/d.5 The study demonstrated that RUTF supplementation
can be successfully administered by community centres outside the
formal healthcare framework.
Research on RUTF home administration without the need for medically trained personnel has yielded acceptable results as well. Linneman
et al tested 3 models: medical professionals administering the treatment;
community health aides administering the treatment to patients referred by medical professionals; and community health aides administering the treatment without the involvement of medical professionals.
Their results showed that level of training was not correlated with better
outcomes and similar results were obtained from the 3 models.6
Additionally, home-based therapy with RUTF has shown superiority to standard therapy in similar settings. The standard treatment
employed to help severely malnourished children is based on World
Health Organization (WHO) guidelines, and is usually administered
in two phases: the first phase involves modest-protein, modest-energy milk-based liquid food and antibiotics, and the second phase uses
high-protein, high-energy milk-based liquid food. In a study comparing this standard therapy to locally produced RUTF therapy in a population of 1200 severely malnourished children in Malawi, Ciliberto
et al showed that the RUTF group had a greater recovery rate and
lower incidence of fever, cough and diarrhea.7
Similarly, in a study of children at risk of malnutrition, but who
are not yet malnourished, RUTF showed superiority to standard supplementary fortified cereal/legume-blended food. Patel et al compared the effectiveness of the standard micronutrient-fortified corn/
soy-blend to RUFT in Malawi and found the latter to be 3 times as
effective as the standard corn/soy-blend.8 Short-term preventive use
of RUTF in nonmalnourished children was also found to be effective
in the Niger in reducing the incidence of wasting and severe wasting.9 Children infected with HIV also benefited from RUTF relative
to those who used traditional foods.3

content
RUTFs are energy-dense, micronutrient-rich, homogeneous lipid pastes. Their contents vary somewhat across geographical regions
depending on the availability of raw materials and industrial capability. However, they are often based on the F-100 formula (the standard therapeutic food deployed for severe malnourishment) with the
addition of peanut butter. Standard RUTFs consist of peanut butter,
milk powder, oil, sugar, vitamins and minerals.3 The main minerals
supplemented are iron, zinc, magnesium, copper, potassium, selenium and iodine. Other micronutrients include, among others, B vitamins such as folate and niacin.4
In terms of caloric content, most RUTFs contain between 520 and
550 kcal/100 g. Of that, 45% to 60% is provided in the form of lipids; another 10% to 12% is provided in the form of proteins.2 Administration
to malnourished children is based on their weight and caloric needs.
Due to their low water content—2.5% at most—RUTFs do not
provide a favorable environment for bacterial growth and have a shelf
life of approximately two years. Additionally, they do not require
cooking and have an acceptable taste to children. All these properties
facilitate their use in remote and rural regions.
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challenges

1.

local production, cost and use
While the effectiveness of RUTF in reducing malnutrition has
been shown in some settings, local production of RUTF remains a
particular challenge. In addition to ingredient availability, the production of RUTF requires—at a minimum—a room free of pests and
a mechanical mixer. Adequate monitoring and quality control is
needed to prevent contamination and ensure safe storage and packaging. RUTF generally contains little water content, making bacterial
contamination difficult, but not impossible. Additionally, due to the
peanut content, aflatoxins produced by Aspergillus are of particular
concern.4 Salmonella contamination has also been reported.10
The cost of RUTF is yet another obstacle. According to the
United Nations Children’s Fund (UNICEF), the price of RUTF has
been steadily decreasing for the past decade,11 but it is still relatively
high. Data from 2013 shows the cost of one RUTF carton containing
150 sachets weighing 92 g each is around US$55. Locally produced
RUTF has generally the same price point as RUTF produced in the
United States or France, with production costs of around US$2.6/
kg. This makes it beyond the reach of many families impacted by
malnutrition.4
Finally, Latham et al argue that RUTF could have significant adverse effects on the health of children targeted with this therapy.10
For instance, RUTFs contain little water but the need for children
to consume water increases with the consumption of RUTFs. This
in turn increases the chances that children may acquire waterborne
illnesses common in famine-prone regions.
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need for future research
Despite the positive results from several trials, some researchers
remain skeptical about the use of RUTF, especially for home-based
malnutrition therapy. Schoonees12 and Latham4 argue that unbiased
evidence is lacking and, as of last year, research is insufficient to positively establish the superiority of RUTF to standard therapy. Gera13
argues that almost all the evidence associated with the use of RUTF
comes from sub-Saharan Africa, making generalizations to other
geographic locations difficult.
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conclusion
Ready-to-use therapeutic foods are relatively affordable and nutritious supplements with a reasonable production potential. While
their home-use remains controversial in some settings, RUTFs have
been shown to be effective in a variety of circumstances. More research is needed to verify these findings and study the use of RUTF
in more diverse situations and purposes, including their preventative
use in children prone to malnutrition.
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Bringing global health home
Interview with Dr Bhooma Bhayana
Sissi Cao (Meds 2016), Han Yan (Meds 2017)
Faculty Reviewer: Dr Bhooma Bhayana, MD, FCFP (Department of Family Medicine)
Dr Bhayana is a family physician in London who also works
with the London InterCommunity Health Center (LIHC) and the
Newcomer Health Project, a Schulich initiative. She graduated
from the Schulich School of Medicine and Dentistry in 1985, after
which she worked in Toronto for 5 years. She is fluent in English,
Hindi and Punjabi, and utilizes all 3 in her community work with
recent immigrants and refugees. We met with Dr Bhayana over the
phone to hear her thoughts on global health, to understand her involvement with multicultural initiatives and to gather advice for
medical students interested in global health.
UWOMJ: What does global health mean to you?
Bhooma Bhayana: Global health is such a broad topic with
so many academic definitions. To me, global health means that
health is beyond what we do within the confines of our clinical encounters. Global health encompasses principles of environmental
health, sustainability, equity and marginalization. When we talk of
globalization, a familiar theme is that in the process of globalizing,
we’ve ignored social justice and equity in health.
Tell us about your work in Toronto and how that sparked your
interest in global health.
In Toronto, I worked with an innovative project called the Immigrant Women’s Health Project based out of the Doctor’s Hospital. We parked a mobile home in front of clothing factories and performed cancer screening for women working in the factories. It was
that initiative that made me realize that “international” issues were
the same issues present in our own backyard. From there, I decided
to really focus on immigrant and refugee health. I came to London
in 1989 and have been practicing here since, in a family practice as
well as with the LIHC and now with the Newcomer Health Project.
Tell us more about the Newcomer Health Project.
From my work with the LIHC, I had seen a number of refugees
and immigrants over the years arrive in London. When I started my
own practice l really missed the work, so I spoke to the executive
director of the Cross Cultural Learner’s Center (CCLC) at the time.
She had identified a real need: when refugees arrived, they could
only use walk-in clinics for medical problems, which addressed immediate concerns but not chronic illnesses that needed follow-up
care. We were inspired by Kevin Pottie, a physician in Ottawa and
champion for refugee health, who had written in the Canadian Family Physician about a program in which medical students took the
initial history at the clinic he worked at. It was a win-win situation:
students would learn about cultural competency and the challenges
faced by refugees, and refugees would have an opportunity to share

their stories, give an in-depth history and begin to look after their
health. We decided to duplicate that here and began a clinic on an
ad-hoc basis. Now, we’re at the point where we’re working with
pediatricians and internal medicine specialists to provide specialty
clinics. It is an ever-evolving process.
What are some challenges facing refugees in Canada today?
There were some very large cuts that were announced to refugee health. Previously, all refugees were covered by the Interim
Federal Health Program (IFHP) and government-assisted refugees
were covered by IFH as well as the Ontario Health Insurance Plan
(OHIP). The IFHP program covered limited dental and prescriptions, providing coverage similar to what someone on Ontario
Works or welfare would receive. When cuts were announced, they
removed both refugee claimants and privately-sponsored refugees
from coverage. People would only be covered if their health concerns were a danger to public safety or public health (homicidal,
infectious), but if they affected just their own health (suicidal),
they weren’t covered. This has created a huge gap for acute care:
for example, there was a very high-profile case in Toronto where
a refugee claimant from Latin America was faced with near-blindness from a retinal detachment. An ophthalmologist at St. Michael’s
Hospital ignored the new policy on a humanitarian basis and performed the surgery for free—the hospital had no choice but to absorb the costs of the surgery because they couldn’t see somebody go
blind for the lack of a simple procedure.
Why do you think it’s important for students to be aware of global health issues?
Western definitely has a really rich history of social justice
within the medical school, and I would encourage students to become involved in its initiatives. When I was a medical student, I
sought out those opportunities—for example, I was on the editorial staff of the University Of Western Ontario Medical Journal
(UWOMJ) and discovered that writing was a good way to help encourage global health initiatives.
As a student, it is really important to know about global health
issues in order to have awareness right at the beginning. We used to
think health was purely biological, and then we began to think of it
as being biological, psychological and social. We are now aware that
it involves the entire ecosystem and that awareness is so important
from the beginning because you begin to see the interconnectedness of things when you study disease processes. When I worked
at the South Riverdale Community Health Center in Toronto, Dr
Michael Rachlis, who was the New Democratic Party (NDP) health
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critic, noticed that a number of children within that community
had disabilities. After the investigations revealed the cause to be environmental lead poisoning, he took a much more global approach
and recognized that he needed to step out of the confines of the examining room and look at what was happening in the environment.
He mobilized the community to stop Canada Metal from pumping
lead into the environment and causing the poisoning. If we begin
with that framework as a student, it really gives us the awareness
needed to engage in health advocacy.

Dr Bhooma Bhayana received the 2013 College of Family Physicians
of Canada (CFPC) Geeta Gupta Award for Equity and Diversity. The
award recognizes the achievements of an outstanding family physician CFPC member (or a team) in active practice who has shown
leadership and advanced awareness working in his or her practice and
community to foster respect and understanding of a minority or underserviced population.

Have you had any international health-related experiences? Do
physicians need to leave Canada to be involved in global health?
As a medical student, I went to India for 4 months and spent
some time in New Delhi and some rural areas surrounding Delhi.
I learned from that international elective the importance of marginalization—I spent a lot of time doing obstetrics and gynecology
and recognized the gender inequity that was part of the developing
world. That carries forward here: when immigrant women come to
Canada, they end up having experienced that marginalization but
also face the additional pressures that come with immigration.
I think we have so many opportunities to do work locally. Although a lot of my patients are refugees or new immigrants, it’s always nice to seek out an additional project outside of practice that
encompasses other interests. The Newcomer Health Project does
that for me. One of my colleagues runs a clinic within the homeless shelter once a week, while another colleague is the physician
representative to the school board and works on lunch programs in
schools with children living in poverty. Engaging in one project outside of regular work is how my colleagues and I seek involvement in
global health locally.
What are some of the concerns of global health today? How have
things changed?
Sustainability and the environment are two huge challenges for
global health in the future, and equity is an issue both internationally and at home. We also need to look at the bigger picture. Global
health is a trans-discipline environment; a big challenge is learning
to work with not just other health care disciplines but also with social scientists and policy makers.
Global health has changed a lot for the better. For one thing
the world has become a much smaller place, so that sense of “us
and them” doesn’t exist now. The model has changed; we recognize
now that we’re all in this together, that we share a responsibility
for the inequities of the world. There’s instead a greater sense of
“we’re all in the same boat”—we’re much more aware of the ethics
of global health.
Anything else you want to share?
For students, engagement in global health can be daunting.
What I would say is to do some soul-searching and find one project
that speaks to your heart. Through the course of your work life, find
one longitudinal project and keep it on the back burner of your dayto-day work life.
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Tuberculosis
Old disease and newcomers
Bashiar Thejeel (Meds 2016), Anthony Chow (Meds 2016)
Faculty Reviewer: Dr Bhooma Bhayana, MD, FCFP (Department of Family Medicine)

mrs malik
A physician working at a local emergency department is summoned to see a patient who is complaining of a worsening cough
and fever. At triage blood pressure was 118/70 mmHg and heart rate
was 72 bpm; the nurse also recorded a temperature of 38.5°C and the
patient seemed to be in distress with an elevated respiratory rate of
22 breaths per minute. Mrs Malik presented to the emergency room
with a 4-week history of worsening cough, fever and night sweats accompanied by hemoptysis. The triage nurse reports that this patient
does not speak English very well and will need an interpreter.
Mrs Malik is a 56-year-old woman of Pakistani descent; she arrived to Canada six months ago as a refugee seeking to start a new
life for her family and herself. Mrs Malik does not have a family
doctor, which is why she presented to the emergency department
when she was feeling ill. She lives with her husband, Khan (age 58),
her children, Ahmed (age 18) and Ayesha (age 17), and her mother,
Asia (age 79). Mrs Malik does not have a significant medical history; she had two normal vaginal deliveries for her children and no
other hospitalizations. Currently she is on no medication and has
no known allergies.
Physical examination reveals a productive cough, with bibasilar
rales in addition to lymph node enlargement in the distribution of the
posterior cervical chain. Mrs Malik seems unwell, as there are signs
of respiratory distress. The physician decides to start the diagnostic
journey with a chest x-ray, along with a complete blood count and cell
differential. The x-ray reveals diffuse pulmonary infiltrates and the
blood test shows leukocytosis. Although necessary, these preliminary
tests only broaden the differential diagnosis for this patient’s condition. Based on these results the pulmonary condition can be infectious, such as pneumonia or tuberculosis; malignant, either a primary
lung cancer or a metastasis from a secondary tumor; or autoimmune,
such as polyangiitis granulomatosis. All of these conditions are very
serious and can result in serious morbidity, so the physician decides
to tackle this daunting differential by further working up the patient.

tuberculosis status of refugees and newcomers
The incidence of tuberculosis (TB) is on a steady decline in Canada over the past 3 decades, but there is disparity among some of the
populations living within Canada. These populations include the Aboriginal populations and populations of refugees and newcomers. Every year Canada takes on approximately 10  000 refugees from areas
of political, cultural and environmental distress.1 These refugees are
exposed to various pathogens that increase their risk of contracting
infectious diseases. Although predeparture screening programs exist,
they may not be rigorous or comprehensive due to the conditions and
circumstances of regions from which refugees originate. Further, international rules encourage the resettlement of all refugees regardless

of medical illness. This is in contrast to other migrant categories in
which individuals may be restricted from immigration to Canada if
they have serious health morbidities. In addition despite the existence
of rigorous screening for government-assisted refugees, there is no
corresponding system for claimants.
One key morbidity relevant to migrants is infection with Mycobacterium tuberculosis. Most of these infections are discovered in the
inactive phase, meaning the patient is a carrier of the illness and is
able to convert into the active state and become symptomatic. The
incidence rate of active TB among the refugee population is 20 times
that of the Canadian-born non-Aboriginal population, which is currently 5 cases per 100 000 persons.2 Individuals with a latent TB
infection comprise 30 to 50% of newcomers, which works out to 1.5
million people in Canada who are carriers of the disease and at risk for
developing the active infection and passing it on.3

what confers risk upon newcomer populations?
Many factors influence the risk that a newcomer incurs for TB
infection while in Canada. The most important predictors of risk include country of origin, migratory category, other comorbidities and
the time since arrival in Canada. Of the 9.2 million cases of active TB
worldwide, most are clustered in endemic areas such sub-Saharan Africa and Asia in which the individuals are more likely to be exposed
to the tuberculin inoculum.4 Further, whether individuals identify as
immigrants or refugees is an indicator of their risk for infection; this
is due to the fact that refugees come from regions in which TB is of
higher prevalence and from relatively poor living circumstances.4 In
addition, individuals with comorbidities, particularly HIV infection,
that reduce the body’s ability to fight off infection are at a greater risk.
Lastly, time since arrival also correlates with infectivity; individuals
who are not diagnosed with TB within the first 5 years of arrival are at
lower risk of developing the infection. The risk is highest within the
first year and dramatically decreases thereafter.4,5 Therefore, based
on these criteria, individuals can be stratified into risk groups.
Table 1: Quick Facts: Incidence of Tuberculosis in Countries of
Canadian Immigrantsa

country

a

incidence rate (per 100 000 people)

Phillipines

265

Pakistan

231

India

176

China

73

Adapted from Citizen and Immigration Canada and World Health Organization.12,13
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Aware of the aforementioned risks, the physician decides to elicit a comprehensive history from Mrs Malik and her family. Mrs Malik
tells the physician that many years ago as a child she had a lung infection that lasted for a very long time but eventually resolved. During
her predeparture medical examination she had a positive TB skin
test; however, her chest x-ray was negative. Currently, she lives in a
one-bedroom apartment along with family. She does not complain
of any other symptoms and says that she has been healthy in the past
with no other health issues. She does not smoke or consume alcohol.
Lab tests for renal function and autoimmune antibodies are negative.
This information and the preliminary tests together suggest an infectious process with a high index of suspicion of TB.
Table 3: Quick Facts: Latent Tuberculosis Infection (LTBI)a
• Affects one third of world’s population.
• Individuals are asymptomatic and noninfectious but are at risk of
developing active disease and becoming infectious.
• Risk of reactivation increases with immunosuppression, malnutrition,
diabetes and alcohol abuse.
• Individuals with LTBI should undergo prophylactic treatment
with isoniazid.
a

Adapted from World Health Organization.14

screening at risk populations
Attempts are made to screen refugee populations for infective
diseases such as TB; however, despite these efforts many individuals
migrate to Canada and become ill with TB. All individuals desiring
entry into Canada, including refugees, are screened with a chest x-ray.
A sputum culture is indicated in those individuals with a positive
screening chest x-ray.3,6 Individuals with an active infection must be
treated and provide proof of treatment and recovery. Most individuals
screened with a chest x-ray fall within the category of latent TB infection. These individuals should report to a health care professional
within 30 days of their arrival in Canada;6 but many individuals with
latent TB never make it to a postarrival health care check-up and thus
they end up falling through the cracks. In addition, despite the efforts
put into the predeparture screening, it is not as efficient as it needs to
be, as it identifies only 1% of active TB cases and 3 to 5% of latent cases
while refugees and newcomers account for 65% of TB cases in Canada.3,7 Furthermore, many issues arise with postlanding management
of individuals who are identified as being carriers of the infection. Individuals often fail to complete screening and report for medical evaluation for a positive screen test. Health practitioners also come short
when it comes to prescribing chemoprophylaxis and this is often followed by poor compliance due to lack of symptoms and long duration
of treatment.8 These pitfalls uncover inadequacies in the health care
system in terms of providing health care to newcomers.
Mrs Malik is confirmed to have an active TB infection based
on a positive stain sputum smear for Mycobacterium tuberculosis,
which revealed acid-fast bacilli. Along with the history of previous
infection, the present symptoms and investigations, the physician
confirms the diagnosis of active TB infection and proceeds with the
treatment of Mrs Malik. The patient is isolated and admitted to the

respirology service for rigorous treatment. Since this is an active case
of TB, the emergency physician goes on to report the case to public
health. Furthermore, Mrs Malik is asked to provide a list of contacts.

management of new cases of tuberculosis in the
refugee population
Treatment regimes and protocols have been developed and tested for both latent and active TB. Ideally individuals are identified in
the latent infection phase and treated before reactivation. Currently the management for latent TB is a 9-month course of isoniazid.9
Many randomized control trials have shown that chemoprophylaxis
is more effective than placebo at preventing reactivation.10 A baseline
evaluation of hepatic function must be done before initiation of treatment since there is a risk of hepatic toxicity.11 A large barrier to chemoprophylaxis is monitoring and ensuring patient compliance to the
9-month regimen, which diminishes the efficacy of risk reduction. In
patients with active TB, the treatment course is much more demanding as it involves 2 phases of treatment and multiple drugs over an extended duration of time. In addition, during the treatment the patient
needs to be kept in isolation to prevent propagation of the infection.
Treatment of active TB includes an initial treatment with isoniazid, rifampin, pyrazinamide and ethambutol for a minimum duration
of 8 weeks.9 Thereafter a continuation phase is started with isoniazid
and rifampin for 26 weeks. At the end of this treatment protocol, investigations such as cultures and x-rays need to demonstrate resolution of the infection. If resolution of the infection is not achieved, the
physician will need to investigate as to whether this due to patient
compliance issues or a drug-resistant infection. During treatment, hepatic function should be monitored for any signs of toxicity.9 Management of an active TB infection extends beyond the infected patient,
as the event must be reported to public health. Furthermore, due to
the potential for transmission, contact tracing must be performed and
contacts must be assessed and treated accordingly. This emphasizes
the importance of early detection and chemoprophylaxis.
Canada is internationally recognized for its efforts in resettling
refugees from all over the world. Many resources are allocated to ensure the success of the resettlement process. Often times, however,
the predeparture process is preferentially resourced, leaving the postlanding procedures without enough support. More awareness needs
to be drawn to the heightened TB risk that our refugees are burdened
with such that our physicians aren’t left “thinking on their feet”.
Table 3: Quick Facts: World Health Organization Recommendations on Tuberculosis Control Using Direct Observed Therapy (DOT)a

five components of dot
1. Political commitment with increased sustained financing
2. Case detection through quality assured bacteriology
3. Standardized treatment with supervision and patient support
4. An effective drug supply and management system
5. Monitoring and evaluation system and impact measurement
a

Adapted from World Health Organization.14
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Be careful eating the local catch
An unusual case of mass scombroid poisoning in deployed forces in Indonesia
Eric Roszell (Meds 2016), Craig Olmstead (Meds 2017)
Faculty Reviewer: Dr William Moote, MD, FRCPC (Department of Medicine, Division of Clinical Immunology & Allergy)

introduction
Our case begins in a setting far removed from a typical North
American hospital. It begins in Sumatra, Indonesia during earthquake recovery efforts in November, 2009. An Australian Defence
Force medical team was deployed to help with the recovery efforts.
After a successful mission providing relief, the deployed forces started to pack up their supplies and prepared to leave in the next few
days. Shortly after dinnertime, however, one of the staff members
presented to the medical staff in the mobile centre with generalized
urticaria.1

initial considerations & response
Acute urticaria, a red itchy rash often referred to as hives, can
have multiple etiologies. The most common causes are related to
allergic reactions to foods, medications, or insect bites. Although
more common in pediatric patients, infections can also lead to acute
urticaria in adults. Rarer causes for adult urticarial include vasculitis and systemic lupus erythematosus, but these usually present
with other physical symptoms.2
Due to the limited resources of the mobile centre and acute
time frame of presentation, full testing could not be completed, so
these rarer causes could not be completely ruled out. Based on the
presentation of acute urticaria in isolation, a tentative diagnosis of
an allergic reaction was given for the staff member and a search
was done to elucidate the trigger for the reaction. Intramuscular
adrenaline, oral promethazine, ranitidine, and intravenous steroids
were administered. Before a trigger for the allergic reaction could
be determined, however, another patient presented with a similar
clinical picture.

additional cases
A second staff member presented with truncal urticaria, oral
angioedema, hoarseness, and dysphagia approximately 20 minutes after the first patient had sought assistance.1 The addition of
a second case to this clinical picture so soon after the initial case,
while not inconsistent with an allergic reaction, raised doubts
about whether a hypersensitivity reaction was truly the underlying
cause.3 This second staff member mentioned that some others were
also feeling unwell and experiencing similar symptoms. Over another 20 minutes, 5 other staff members presented with varying degrees of urticaria, erythema, abdominal pain, and dysphagia. Given
the setting—a mobile Australian Defence Force base in Indonesia—
this massive influx of new patients had several important implications. Due to the small size of the mobile centre and because many
of the supplies had been packed, the treatment capacity of the centre was quickly overwhelmed by this sudden influx of patients. The
supply of adrenaline and steroids was quickly exhausted, and there

were only two patient monitors available. To further compound
this resource shortage, one of the senior nurses also began to show
symptoms. Panic set in among the staff as they wondered about the
identity of the trigger for these reactions. The search for a causative
agent was intensified. The patients had some similar exposures that
were investigated, such as a wet muddy field and a lightly damaged
building they had visited previously; however, no causative agent
could be found. Ingested toxins were also considered but none were
identified at this point.1

response & resolution
As no causative agent could be found, evacuation of the patients to a nearby offshore ship, the HMAS (Her Majesty’s Australian Ship) Kanimbla, was requested. Medical staff on board the
ship were informed of the situation and proceeded to conduct an
internet search for possible causative agents. That search suggested the possibility of scombroid poisoning, a type of food poisoning
associated with the consumption of fish. Further investigation revealed all affected patients had eaten 3 servings or more of a locally acquired white meat dish believed to contain fish. This dish
was referred to as “ficken” by the Australian Defence Force medical
team as a joke because of the inability to ascertain exactly what kind
of meat it was made from. Upon questioning, other staff personnel who ingested smaller quantities of ficken reported some mild
nausea and abdominal cramping. Based on these findings, a clinical diagnosis of scombroid toxicity was made and all patients were
successfully treated with intramuscular adrenaline, ranitidine, intravenous steroids, and oral promethazine. Additional supplies and
personnel were dispatched from the HMAS Kanimbla to assist with
treatment.1

scombroid poisoning
Scombroid food poisoning generally occurs when histidine-rich
fish are consumed after improper storage.1 Fish of the Scombroidei genus, such as tuna or mackerel, are the most common culprits,
though other species fish have been implicated.1,4,5 The pathogenesis of scombroid poisoning is believed to be the conversion of histidine
to histamine by bacteria, often gram-negative enteric bacilli such as
Escherichia coli.1,6 The conversion process involves a decarboxylase
enzyme, and occurs primarily when the fish is stored above 16°C.1
Other biogenic amines may play a role, though their effects have yet
to be established.1,5 Nevertheless, the result is, in effect, poisoning by
an overabundance of histamine.1,3-5 Symptoms vary, but are extremely similar to an immediate IgE-mediated hypersensitivity reaction
and can include flushing, widespread urticaria, edema, nausea, and
bronchospasm.1,3,7 Initial onset of symptoms often occurs within one
hour of consumption of the affected food, and can persist for up to 36
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hours.1,4 Scombroid food poisoning can be extremely difficult to diagnose, due to the similarity of its symptoms to those of an allergic reaction and its atypical method of action. While scombroid poisoning
does involve bacterial spoiling of food, unlike more common forms
of food poisoning, killing the responsible bacteria does not eliminate
the toxin—high heat does not destroy histamine, so properly cooked
fish can still cause scombroid poisoning.1,5 Furthermore, there may
be no obvious signs of spoiling, as histamine does not change the odor
or appearance of the fish.4
Diagnosis of scombroid poisoning can often be made clinically,
though additional testing may be used for confirmation.1,6,7 The timing of symptoms, with an initial presentation shortly after consumption, is an important factor but may not help distinguish scombroid
from a standard allergic reaction.5 The keys to clinical diagnosis are
the absence of a history with allergies and the simultaneous onset
of symptoms with other patients.1,5-7 Blood histamine levels will
be highly elevated initially, with a significant reduction within 24
hours.6 Levels of histamine or histamine byproducts in the urine may
also be elevated.6 If a sample is available, direct testing of the ingested fish for histamine concentrations can also be diagnostic.3,6 In our
case, the situation precluded use of supplementary diagnostic tools,
and the diagnosis was made clinically.1
Treatment for scombroid poisoning is supportive in nature.1,7
Fast-acting antihistamines, fluids, and antipyretic agents should be
used to control symptoms as needed.1,4,7 Promethazine, the antihistamine used in this case, is an older, first generation sedating antihistamine that is not frequently used in Canada; diphenhydramine
is traditionally the emergency antihistamine of choice. In extreme
cases, where closure of the airway becomes a concern, administration of adrenaline may be necessary.1,7 Use of corticosteroids has
been reported and was used in this case, although their value has
been questioned.1,3,4,7 Patients should recover within 36 hours as the
excess histamine is cleared from the body, though careful monitoring is required to ensure symptoms are responding appropriately to
medication.1,3-5

However, this case also demonstrates the value of open lines of
communication. The ability to consult outside support and subsequently to call in additional resources was instrumental in achieving a successful response to this unique medical crisis.1 The insights
gained from this case are relevant to medicine practiced in situations
with limited resources and in situations where information is limited due to a culture gap. These lessons are increasingly important as
medicine continues to be practiced from a more global perspective.
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conclusion
This case illustrates some of the challenges of practicing medicine in a more remote area with limited supplies and resources, and
where backup cannot be accessed quickly. Treatment of patients
was initially hindered both because of a supply shortage and because health care providers who would normally provide treatment
were among the patients. Assistance eventually was provided by the
HMAS Kanimbla, but there was a 4-hour delay between the request
for assistance and help arriving. The lack of medical and human resources made the search for the causative agent more difficult as well.
This is highlighted by the fact that foodborne illness was considered
but initially ruled out due to inadequate investigation. Moreover, ignorance about the regional cuisine—in this case, the mystery meat in
ficken—proved to be a barrier in establishing a diagnosis, as the common history of fish consumption was revealed only after scombroid
poisoning was proposed as a possibility, despite a concerted effort to
find a connection between patients. This highlights how practicing
medicine in unfamiliar locations or cultures can result in missing
knowledge, and therefore lead to an incomplete history.
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